Prof Tim Beukelman
Senior Lecturer
School of Medicine
College of Health
Timothy Beukelman is a Professor of Paediatrics at Adelaide University and a Senior Consultant in Paediatric Rheumatology at Women's and Children's Health Network. Tim is an accomplished clinical epidemiologist, specialising in pharmacoepidemiology. The primary focus of his research has been optimising the treatment of juvenile idiopathic arthritis using various research approaches including retrospective analysis of observational data, prospective observational data collection and analysis, quality improvement, clinical treatment guideline development, decision analysis, and clinical trials. He has particular expertise in the design, conduct, and interpretation of results of clinical studies using large complex data sets collected for non-research purposes, such as administrative data and electronic medical records. Tim is also a key founder and the current Scientific Director of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry, established in 2015 as a longitudinal observational registry which now includes over 15,000 participants with childhood-onset rheumatic disease at 70 clinical sites in the United States and Canada. In addition to his academic research career, he has extensively collaborated with and consulted for pharmaceutical companies to design rigorous observational studies and provide expert analyses of results.
| Date | Position | Institution name |
|---|---|---|
| 2026 - ongoing | Professor of Paediatrics | Adelaide University |
| 2024 - ongoing | Senior Consultant, Paediatric Rheumatology | Women's and Children's Health Network |
| 2007 - 2021 | Assoc Professor of Pediatrics | University of Alabama at Birmingham |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2004 - 2008 | University of Pennsylvania | United States | MSCE |
| 1997 - 2001 | Washington University in St. Louis | United States | MD |
| 1993 - 1997 | University of Illinois Urbana-Champaign | United States | BS |
| Date | Title | Institution | Country |
|---|---|---|---|
| 2004 - 2007 | Pediatric Rheumatology | Children's Hospital of Philadelphia | United States |
| 2001 - 2004 | Pediatrics | Cincinnati Children's Hospital Medical Center | United States |
| Date | Title | Institution name | Country |
|---|---|---|---|
| 2025 | FRACP | Royal Australasian College of Physicians | Australia |
| Year | Citation |
|---|---|
| 2026 | Ho, J. N., Hillen, J., Nassar, N., Zoega, H., Beukelman, T., Pratt, N., & Daniels, B. (2026). Uptake and Use of Biologic Therapies in Paediatric Immune-Mediated Inflammatory Diseases: An Australian Population-Based Study. Pharmacoepidemiology and Drug Safety, 35(7), e70412-1-e70412-10. |
| 2026 | Xie, F., Beukelman, T., McCormick, N. P., & Curtis, J. R. (2026). Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drug. Arthritis Care and Research, 10 pages. |
| 2025 | Correll, C., Burciu, A., Bansal, A., Dennos, A., Narayanswamy, D., Aubrun, E., . . . Shishov, M. (2025). Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry. Pediatric Rheumatology, 23(1), 10 pages. Scopus1 WoS1 Europe PMC1 |
| 2025 | Srinivasalu, H., Beukelman, T., Dennos, A., Chen, A., Correll, C., Ringold, S., . . . Ede, K. (2025). Juvenile Psoriatic Arthritis Inception Cohort in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: Characteristics and Early Disease Outcomes. Journal of Rheumatology, 52(10), 1013-1020. Scopus1 |
| 2025 | Ringold, S., Ong, M. S., Tomlinson, G., Natter, M. D., Schanberg, L. E., Del Gaizo, V., . . . Davis, A. (2025). Three-Year Outcomes and Latent Class Trajectory Analysis of the Childhood Arthritis and Rheumatology Research Alliance Polyarticular JIA Consensus Treatment Plans Study. Arthritis and Rheumatology, 77(10), 1433-1441. Scopus6 Europe PMC5 |
| 2024 | Beukelman, T., Mudano, A., Stewart, P., Venkatachalam, S., Xie, F., George, M., . . . Curtis, J. R. (2024). Generating Real-World Evidence From the Excellence Network in Rheumatology. Pharmacoepidemiology and Drug Safety, 33(12), 7 pages. Scopus8 WoS7 Europe PMC5 |
| 2024 | Mahesri, M., Lee, S. B., Levin, R., Imren, S., Zhang, L., Beukelman, T., . . . Desai, R. J. (2024). Infrequent Resolution of Vaso-Occlusive Crises in Routine Clinical Care Among Patients Mimicking the Exa-Cel Trial Population: A Cohort Study of Medicaid Enrollees. Clinical Pharmacology and Therapeutics, 116(6), 1572-1579. |
| 2024 | Beukelman, T., Su, Y., Xie, F., George, M. D., England, B. R., Curtis, C., . . . Curtis, J. R. (2024). Using Electronic Health Records and Linked Claims Data to Assess New Medication Use and Primary Nonadherence in Rheumatology Patients. Arthritis Care and Research, 76(4), 550-558. Scopus9 WoS8 Europe PMC8 |
| 2024 | Mannion, M. L., Amin, S., Balevic, S., Chang, M. L., Correll, C. K., Kearsley-Fleet, L., . . . Beukelman, T. (2024). Comparative Effectiveness of a Second Tumor Necrosis Factor Inhibitor Versus a Non–Tumor Necrosis Factor Biologic in the Treatment of Patients With Polyarticular-Course Juvenile Idiopathic Arthritis. Arthritis Care and Research, 76(8), 1090-1098. Scopus6 WoS6 Europe PMC6 |
| 2024 | Saito, K., Gabbeta, A., Mulvihill, E., Al-Jaberi, L., Beukelman, T., Lewis, J. D., . . . Horton, D. B. (2024). Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis. Pharmacoepidemiology and Drug Safety, 33(5), 11 pages. |
| 2023 | Ioannou, Y., Beukelman, T., Murray, M., & Erkan, D. (2023). Incidence of Antiphospholipid Syndrome: Is Estimation Currently Possible?. EUROPEAN JOURNAL OF RHEUMATOLOGY, 10(1), 39-44. WoS8 |
| 2023 | Xie, F., Beukelman, T., Sun, D., Yun, H., & Curtis, J. R. (2023). Identifying inpatient mortality in MarketScan claims data using machine learning. Pharmacoepidemiology and Drug Safety, 32(11), 1299-1305. Scopus3 WoS3 Europe PMC3 |
| 2023 | Beukelman, T., Chen, L., Annapureddy, N., Oates, J., Clowse, M. E. B., Long, M., . . . Curtis, J. R. (2023). Using pooled electronic health records data to conduct pharmacoepidemiology safety studies: Challenges and lessons learned. Pharmacoepidemiology and Drug Safety, 32(9), 969-977. Scopus5 WoS6 Europe PMC4 |
| 2023 | Santoro, J. D., Beukelman, T., Hemingway, C., Hokkanen, S. R. K., Tennigkeit, F., & Chitnis, T. (2023). Attack phenotypes and disease course in pediatric MOGAD. Annals of Clinical and Translational Neurology, 10(5), 672-685. Scopus29 WoS26 Europe PMC25 |
| 2023 | Jackson, L. E., Khullar, N., Beukelman, T., Chapleau, C., Kamath, A., Cron, R. Q., & Chatham, W. W. (2023). Prediction of Survival by IL-6 in a Randomized Placebo-Controlled Trial of Anakinra in COVID-19 Cytokine Storm. Viruses, 15(10), 13 pages. Scopus8 WoS7 Europe PMC6 |
| 2023 | Correll, C. K., Stryker, S., Collier, D., Phillips, T. A., Dennos, A. C., Balevic, S. J., & Beukelman, T. (2023). Occurrence of adverse events and change in disease activity after initiation of etanercept in paediatric patients with juvenile psoriatic arthritis in the CARRA Registry. Rmd Open, 9(2), 12 pages. Scopus3 WoS3 Europe PMC1 |
| 2023 | Verstegen, R. H. J., Shrader, P., Balevic, S. J., Beukelman, T., Correll, C., Dennos, A., . . . Feldman, B. M. (2023). Dosing Variation at Initiation of Adalimumab and Etanercept and Clinical Outcomes in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance Registry Study. Arthritis Care and Research, 75(2), 410-422. Scopus4 WoS5 Europe PMC3 |
| 2023 | Shiff, N. J., Shrader, P., Correll, C. K., Dennos, A., Phillips, T., Beukelman, T., . . . Dowling, J. (2023). Trajectories of disease activity in patients with JIA in the Childhood Arthritis and Rheumatology Research Alliance Registry. Rheumatology United Kingdom, 62(2), 804-814. Scopus3 WoS3 Europe PMC3 |
| 2023 | Borgia, R. E., Gurka, M. J., Filipp, S. L., Elder, M., Cardel, M., Shiff, N. J., . . . Dorsey, E. (2023). Race, ethnicity and patient-reported outcomes in childhood-onset systemic lupus erythematosus. Clinical and Experimental Rheumatology, 41(1), 186-194. Scopus4 Europe PMC3 |
| 2023 | Smitherman, E. A., Chahine, R. A., Bitencourt, N., Rahman, A. K. M. F., Lawson, E. F., Chang, J. C., . . . Dorsey, E. (2023). Patient-Reported Outcomes Among Transition-Age Young Adults With Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry. Journal of Rheumatology, 50(1), 98-106. Scopus10 Europe PMC5 |
| 2023 | Smitherman, E. A., Chahine, R. A., Beukelman, T., Lewandowski, L. B., Rahman, A. K. M. F., Wenderfer, S. E., . . . DeSantis, E. (2023). Childhood-Onset Lupus Nephritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: Short-Term Kidney Status and Variation in Care. Arthritis Care and Research, 75(7), 1553-1562. Scopus15 WoS14 Europe PMC9 |
| 2023 | Roberts, J. E., Williams, K., Dallas, J., Eckert, M., Huie, L., Smitherman, E., . . . Dickson, T. (2023). Insurance Status and Tumor Necrosis Factor Inhibitor Initiation Among Children With Juvenile Idiopathic Arthritis in the CARRA Registry. Journal of Rheumatology, 50(8), 1047-1057. Scopus4 |
| 2023 | Ringold, S., Dennos, A. C., Kimura, Y., Beukelman, T., Shrader, P., Phillips, T. A., . . . Delnay, N. (2023). Disease Recapture Rates After Medication Discontinuation and Flare in Juvenile Idiopathic Arthritis: An Observational Study Within the Childhood Arthritis and Rheumatology Research Alliance Registry. Arthritis Care and Research, 75(4), 715-723. Scopus14 WoS13 Europe PMC9 |
| 2023 | Beukelman, T., Long, M., Rhee, R. L., Kappelman, M., Merkel, P. A., Nowell, W. B., . . . Curtis, J. R. (2023). Assessment of Real-World Patient-Reported Outcomes in Patients Initiating Biologic Agents for the Treatment of Autoimmune Diseases: An Observational Study in Four Patient-Powered Research Networks. PATIENT-RELATED OUTCOME MEASURES, 14, 171-180. WoS1 |
| 2022 | Beukelman, T., Tomlinson, G., Nigrovic, P. A., Dennos, A., Del Gaizo, V., Jelinek, M., . . . James, K. (2022). First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans. Pediatric Rheumatology, 20(1), 10 pages. Scopus23 WoS24 Europe PMC20 |
| 2022 | Mannion, M. L., Xie, F., & Beukelman, T. (2022). Investigation of Inactive Disease States Among Patients With Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry. Acr Open Rheumatology, 4(9), 825-831. Scopus6 WoS6 |
| 2022 | Zhao, Y., Sullivan, E., Son, M. B., & Beukelman, T. (2022). Psoriasis rate is increased by the exposure to TNF inhibition in children with JIA. Annals of the Rheumatic Diseases, 81(5), 662-665. Scopus8 WoS8 Europe PMC9 |
| 2022 | Correll, C. K., Shrader, P., Dennos, A., Phillips, T., Shiff, N. J., Verstegen, R. H. J., & Beukelman, T. (2022). Effectiveness and Safety of High-Dose Biologics in Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance. Arthritis Care and Research, 74(11), 1770-1779. Scopus11 WoS11 Europe PMC10 |
| 2022 | Hahn, T., Daymont, C., Beukelman, T., Groh, B., Hays, K., Bingham, C. A., & Scalzi, L. (2022). Correction: Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry (Pediatric Rheumatology, (2022), 20, 1, (107), 10.1186/s12969-022-00770-y). Pediatric Rheumatology, 20(1), 1 page. |
| 2022 | Neely, J., Ardalan, K., Huber, A., Kim, S., Abel, N., Abulaban, K., . . . Dorsey, E. (2022). Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry. Pediatric Rheumatology, 20(1), 50. Scopus12 Europe PMC11 |
| 2022 | Hahn, T., Daymont, C., Beukelman, T., Groh, B., Hays, K., Bingham, C. A., . . . Dickson, T. (2022). Placeholder TextIntraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry. Pediatric Rheumatology, 20(1), 8 pages. Scopus9 WoS8 Europe PMC5 |
| 2022 | Soulsby, W. D., Balmuri, N., Cooley, V., Gerber, L. M., Lawson, E., Goodman, S., . . . DeSantis, E. (2022). Social determinants of health influence disease activity and functional disability in Polyarticular Juvenile Idiopathic Arthritis. Pediatric Rheumatology, 20(1), 18. Scopus18 Europe PMC18 |
| 2021 | Beukelman, T., Lougee, A., Matsouaka, R. A., Collier, D., Rumsey, D. G., Schenfeld, J., . . . DeSantis, E. (2021). Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry. Pediatric Rheumatology, 19(1), 10 pages. Scopus6 WoS5 Europe PMC4 |
| 2021 | Mannion, M. L., Xie, F., Horton, D. B., Ringold, S., Correll, C. K., Dennos, A., . . . Dover, S. (2021). Biologic switching among nonsystemic juvenile idiopathic arthritis patients: A cohort study in the childhood arthritis and rheumatology research alliance registry. Journal of Rheumatology, 48(8), 1322-1329. Scopus22 WoS22 Europe PMC20 |
| 2021 | Rumsey, D. G., Lougee, A., Matsouaka, R., Collier, D. H., Schanberg, L. E., Schenfeld, J., . . . Delnay, N. (2021). Juvenile Spondyloarthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: High Biologic Use, Low Prevalence of HLA–B27, and Equal Sex Representation in Sacroiliitis. Arthritis Care and Research, 73(7), 940-946. Scopus23 WoS19 Europe PMC18 |
| 2021 | Horton, D. B., Xie, F., Chen, L., Mannion, M. L., Curtis, J. R., Strom, B. L., & Beukelman, T. (2021). Oral Glucocorticoids and Incident Treatment of Diabetes Mellitus, Hypertension, and Venous Thromboembolism in Children. American Journal of Epidemiology, 190(3), 403-412. Scopus16 WoS11 Europe PMC10 |
| 2021 | Horton, D. B., Salas, J., Wec, A., Kohlheim, M., Kapadia, P., Beukelman, T., . . . Rosenthal, M. (2021). Making Decisions About Stopping Medicines for Well-Controlled Juvenile Idiopathic Arthritis: A Mixed-Methods Study of Patients and Caregivers. Arthritis Care and Research, 73(3), 374-385. Scopus22 WoS23 Europe PMC20 |
| 2021 | Shiff, N. J., & Beukelman, T. (2021). Pharmacosurveillance in Juvenile Idiopathic Arthritis. Rheumatic Disease Clinics of North America, 47(4), 643-653. Scopus7 WoS7 Europe PMC7 |
| 2021 | Balmuri, N., Soulsby, W. D., Cooley, V., Gerber, L., Lawson, E., Goodman, S., . . . DeSantis, E. (2021). Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis. Pediatric Rheumatology, 19(1), 122. Scopus11 Europe PMC9 |
| 2021 | Maller, J., Fox, E., Park, K. T., Paul, S. S., Baszis, K., Borocco, C., . . . Ringold, S. (2021). Inflammatory bowel disease in children with systemic juvenile idiopathic arthritis. Journal of Rheumatology, 48(4), 567-574. Scopus10 Europe PMC7 |
| 2021 | Kimura, Y., Schanberg, L. E., Tomlinson, G. A., Riordan, M. E., Dennos, A. C., Del Gaizo, V., . . . Guevara, M. (2021). Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans. Arthritis and Rheumatology, 73(10), 1898-1909. Scopus39 Europe PMC33 |
| 2021 | Jones, J. T., Smith, C., Becker, M. L., Lovell, D., Abel, N., Abulaban, K., . . . Dorsey, E. (2021). Down Syndrome–Associated Arthritis Cohort in the New Childhood Arthritis and Rheumatology Research Alliance Registry: Clinical Characteristics, Treatment, and Outcomes. Arthritis Care and Research, 73(12), 1739-1745. Scopus16 Europe PMC12 |
| 2021 | Dave, I., Estroff, B., Gergely, T., Rostad, C. A., Ponder, L. A., McCracken, C., . . . Donaldson, B. (2021). Impact of the Season of Birth on the Development of Juvenile Idiopathic Arthritis in the United States: A Nationwide Registry-based Study. Journal of Rheumatology, 48(12), 1856-1862. Scopus1 Europe PMC1 |
| 2021 | Ong, M. S., Ringold, S., Kimura, Y., Schanberg, L. E., Tomlinson, G. A., Natter, M. D., . . . Dingle, J. (2021). Improved Disease Course Associated With Early Initiation of Biologics in Polyarticular Juvenile Idiopathic Arthritis: Trajectory Analysis of a Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans Study. Arthritis and Rheumatology, 73(10), 1910-1920. Scopus37 Europe PMC28 |
| 2020 | Brunner, H. I., Schanberg, L. E., Kimura, Y., Dennos, A., Co, D. O., Colbert, R. A., . . . Beukelman, T. (2020). New Medications Are Needed for Children With Juvenile Idiopathic Arthritis. Arthritis and Rheumatology, 72(11), 1945-1951. Scopus54 WoS50 Europe PMC47 |
| 2020 | Ringold, S., Schrandt, S., Creek, E. L., Beukelman, T., Angeles-Han, S. T., & Lovell, D. J. (2020). Reply. Arthritis and Rheumatology, 72(6), 1040-1041. |
| 2020 | Eloseily, E. M., Weiser, P., Crayne, C. B., Haines, H., Mannion, M. L., Stoll, M. L., . . . Cron, R. Q. (2020). Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis. Arthritis and Rheumatology, 72(2), 326-334. Scopus244 WoS227 Europe PMC211 |
| 2020 | Tory, H., Zurakowski, D., Kim, S., Abramson, L., Anderson, E., Andrew, M., . . . Simmons, M. (2020). Patient and physician discordance of global disease assessment in juvenile dermatomyositis: Findings from the Childhood Arthritis & Rheumatology Research Alliance Legacy Registry. Pediatric Rheumatology, 18(1), 5. Scopus15 Europe PMC12 |
| 2019 | Crayne, C. B., Mitchell, C., & Beukelman, T. (2019). Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review. Pediatric Rheumatology, 17(1), 8 pages. Scopus12 WoS9 Europe PMC12 |
| 2019 | Neely, J., Long, C. S., Sturrock, H., Kim, S., Abramson, L., Anderson, E., . . . Sherman, Y. (2019). Association of Short-Term Ultraviolet Radiation Exposure and Disease Severity in Juvenile Dermatomyositis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. Arthritis Care and Research, 71(12), 1600-1605. Scopus17 WoS16 Europe PMC14 |
| 2019 | Connelly, M., Weiss, J. E., Abramson, L., Anderson, E., Andrew, M., Battle, N., . . . Singer, N. (2019). Pain, functional disability, and their Association in Juvenile Fibromyalgia Compared to other pediatric rheumatic diseases. Pediatric Rheumatology, 17(1), 7 pages. Scopus20 WoS19 Europe PMC19 |
| 2019 | Schanberg, L. E., Ramanan, A. V., De Benedetti, F., Beukelman, T., Eakin, G. S., Del Gaizo, V., . . . Kimura, Y. (2019). Toward Accelerated Authorization and Access to New Medicines for Juvenile Idiopathic Arthritis. Arthritis and Rheumatology, 71(12), 1976-1984. Scopus11 WoS10 Europe PMC6 |
| 2019 | Ringold, S., Angeles-Han, S. T., Beukelman, T., Lovell, D., Cuello, C. A., Becker, M. L., . . . Reston, J. (2019). 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis. Arthritis Care and Research, 71(6), 717-734. Scopus296 WoS245 Europe PMC199 |
| 2019 | Angeles-Han, S. T., Ringold, S., Beukelman, T., Lovell, D., Cuello, C. A., Becker, M. L., . . . Reston, J. (2019). 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis. Arthritis Care and Research, 71(6), 703-716. Scopus249 WoS205 Europe PMC179 |
| 2019 | Dammling, C., Waite, P., & Beukelman, T. (2019). Primary Oral Presentation of Sarcoidosis in a Pediatric Patient. Journal of Oral and Maxillofacial Surgery, 77(6), 1180-1186. Scopus4 WoS2 Europe PMC1 |
| 2019 | Ringold, S., Angeles-Han, S. T., Beukelman, T., Lovell, D., Cuello, C. A., Becker, M. L., . . . Reston, J. (2019). 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis. Arthritis and Rheumatology, 71(6), 846-863. Scopus181 WoS152 Europe PMC130 |
| 2019 | Angeles-Han, S. T., Ringold, S., Beukelman, T., Lovell, D., Cuello, C. A., Becker, M. L., . . . Reston, J. (2019). 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis. Arthritis and Rheumatology, 71(6), 864-877. Scopus78 WoS71 Europe PMC62 |
| 2019 | Angeles-Han, S. T., Lo, M. S., Henderson, L. A., Lerman, M. A., Abramson, L., Cooper, A. M., . . . Egla Rabinovich, C. (2019). Childhood arthritis and rheumatology research alliance consensus treatment plans for juvenile idiopathic arthritis–Associated and idiopathic chronic anterior uveitis. Arthritis Care and Research, 71(4), 482-491. Scopus90 WoS72 Europe PMC64 |
| 2019 | Hinze, C. H., Foell, D., Johnson, A. L., Spalding, S. J., Gottlieb, B. S., Morris, P. W., . . . Lovell, D. J. (2019). Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy. Arthritis and Rheumatology, 71(3), 451-459. Scopus44 WoS44 Europe PMC39 |
| 2019 | Beukelman, T., Xie, F., & Foeldvari, I. (2019). The prevalence of localised scleroderma in childhood assessed in the administrative claims data from the united states. Journal of Scleroderma and Related Disorders, 4(1), 77-78. Scopus12 WoS11 Europe PMC10 |
| 2019 | Beukelman, T., & Nigrovic, P. A. (2019). Juvenile idiopathic arthritis: An idea whose time has gone?. Journal of Rheumatology, 46(2), 124-126. Scopus18 WoS16 Europe PMC14 |
| 2019 | Eloseily, E. M. A., Minoia, F., Crayne, C. B., Beukelman, T., Ravelli, A., & Cron, R. Q. (2019). Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis. Acr Open Rheumatology, 1(6), 345-349. Scopus67 WoS60 |
| 2019 | Wu, E. Y., Li, S. C., Torok, K. S., Virkud, Y. V., Fuhlbrigge, R. C., Rabinovich, C. E., . . . Shaham, B. (2019). Baseline Description of the Juvenile Localized Scleroderma Subgroup From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. Acr Open Rheumatology, 1(2), 119-124. Scopus48 |
| 2019 | Leong, J. Y., Chen, P., Yeo, J. G., Ally, F., Chua, C., Hazirah, S. N., . . . Giannini, E. H. (2019). Immunome perturbation is present in patients with juvenile idiopathic arthritis who are in remission and will relapse upon anti-TNFα withdrawal. ANNALS OF THE RHEUMATIC DISEASES, 78(12), 1712-1721. WoS24 |
| 2019 | Weiss, J. E., Schikler, K. N., Boneparth, A. D., Connelly, M., Abramson, L., Anderson, E., . . . Zhu, A. (2019). Demographic, clinical, and treatment characteristics of the juvenile primary fibromyalgia syndrome cohort enrolled in the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. PEDIATRIC RHEUMATOLOGY, 17(1), 8 pages. WoS15 |
| 2018 | Caughey, G. E., Gabb, G., Ronson, S., Ward, M., Hill, C., Beukelman, T. G., & Limaye, V. (2018). Association of Statin Exposure with Histologically-Confirmed Idiopathic Inflammatory Myositis in an Australian Population. JAMA Internal Medicine, 178(9), 1224-1229. Scopus25 WoS22 Europe PMC17 |
| 2018 | Lovell, D. J., Johnson, A. L., Huang, B., Gottlieb, B. S., Morris, P. W., Kimura, Y., . . . Giannini, E. H. (2018). Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease. Arthritis and Rheumatology, 70(9), 1508-1518. Scopus37 WoS33 Europe PMC31 |
| 2018 | Nigrovic, P. A., Beukelman, T., Tomlinson, G., Feldman, B. M., Schanberg, L. E., & Kimura, Y. (2018). Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST). Clinical Trials, 15(3), 268-277. Scopus25 WoS21 Europe PMC16 |
| 2018 | Crayne, C. B., Eloseily, E., Mannion, M. L., Azerf, S. P., Weiser, P., Beukelman, T., . . . Cron, R. Q. (2018). Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature. Pediatric Rheumatology, 16(1), 6 pages. Scopus48 WoS41 Europe PMC38 |
| 2018 | Stoll, M. L., Amin, D., Powell, K. K., Poholek, C. H., Strait, R. H., Aban, I., . . . Waite, P. D. (2018). Risk factors for intraarticular heterotopic bone formation in the temporomandibular joint in Juvenile idiopathic arthritis. Journal of Rheumatology, 45(9), 1301-1307. Scopus31 WoS27 Europe PMC23 |
| 2018 | Crayne, C. B., & Beukelman, T. (2018). Juvenile Idiopathic Arthritis: Oligoarthritis and Polyarthritis. Pediatric Clinics of North America, 65(4), 657-674. Scopus58 WoS32 Europe PMC24 |
| 2018 | Beukelman, T., Xie, F., Chen, L., Horton, D. B., Lewis, J. D., Mamtani, R., . . . Curtis, J. R. (2018). Risk of malignancy associated with paediatric use of tumour necrosis factor inhibitors. Annals of the Rheumatic Diseases, 77(7), 1012-1016. Scopus60 WoS52 Europe PMC41 |
| 2018 | Beukelman, T., Xie, F., & Foeldvari, I. (2018). Assessing the prevalence of juvenile systemic sclerosis in childhood using administrative claims data from the United States. Journal of Scleroderma and Related Disorders, 3(2), 189-190. Scopus37 WoS34 Europe PMC24 |
| 2018 | Mor-Vaknin, N., Rivas, M., Legendre, M., Mohan, S., Yuanfan, Y., Mau, T., . . . Markovitz, D. M. (2018). High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti–Tumor Necrosis Factor Therapy. Arthritis and Rheumatology, 70(4), 594-605. Scopus14 WoS14 Europe PMC12 |
| 2018 | Weiss, P. F., Xiao, R., Brandon, T. G., Pagnini, I., Wright, T. B., Beukelman, T., . . . Feudtner, C. (2018). Comparative effectiveness of tumor necrosis factor agents and disease-modifying antirheumatic therapy in children with enthesitis-related arthritis: The first year after diagnosis. Journal of Rheumatology, 45(1), 107-114. Scopus16 WoS15 Europe PMC9 |
| 2018 | Rubinstein, T. B., Mowrey, W. B., Ilowite, N. T., Wahezi, D. M., Abramson, L., Anderson, E., . . . Simmons, M. (2018). Delays to Care in Pediatric Lupus Patients: Data From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. Arthritis Care and Research, 70(3), 420-427. Scopus32 Europe PMC28 |
| 2018 | Stevens, B. E., Torok, K. S., Li, S. C., Hershey, N., Curran, M., Higgins, G. C., . . . Ruth, N. (2018). Clinical Characteristics and Factors Associated With Disability and Impaired Quality of Life in Children With Juvenile Systemic Sclerosis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. Arthritis Care and Research, 70(12), 1806-1813. Scopus46 Europe PMC32 |
| 2018 | Samad, A., Stoll, M. L., Lavi, I., Hsu, J. J., Strand, V., Robinson, T. N., . . . Ruth, N. (2018). Adiposity in juvenile psoriatic arthritis. Journal of Rheumatology, 45(3), 411-418. Scopus17 Europe PMC13 |
| 2018 | Brunner, H. I., Tzaribachev, N., Vega-Cornejo, G., Louw, I., Berman, A., Calvo Penadés, I., . . . Espada, G. (2018). Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study. Arthritis and Rheumatology, 70(7), 1144-1154. Scopus67 Europe PMC44 |
| 2017 | Mehta, J., & Beukelman, T. (2017). Biologic Agents in the Treatment of Childhood-Onset Rheumatic Disease. Journal of Pediatrics, 189, 31-39. Scopus5 WoS2 Europe PMC1 |
| 2017 | Stoll, M. L., Grubbs, J. A., Beukelman, T., Mannion, M. L., Jester, T. W., Cron, R. Q., & Crain, M. J. (2017). Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: A retrospective study. Pediatric Rheumatology, 15(1), 6 pages. Scopus7 WoS6 Europe PMC5 |
| 2017 | Beukelman, T., Curtis, J. R., & Saag, K. G. (2017). Serious Infections in Childhood-Onset Systemic Lupus Erythematosus: Using Administrative Claims Data to Investigate Disease Outcomes. Arthritis Care and Research, 69(11), 1617-1619. Scopus3 WoS3 Europe PMC1 |
| 2017 | Curtis, J. R., Xie, F., Smith, C., Saag, K. G., Chen, L., Beukelman, T., . . . Kertesz, S. (2017). Changing Trends in Opioid Use Among Patients With Rheumatoid Arthritis in the United States. Arthritis and Rheumatology, 69(9), 1733-1740. Scopus67 WoS66 Europe PMC59 |
| 2017 | Falvey, S., Shipman, L., Ilowite, N., & Beukelman, T. (2017). Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis. Pediatric Rheumatology, 15(1), 6 pages. Scopus23 WoS22 Europe PMC19 |
| 2017 | Gmuca, S., Xiao, R., Brandon, T. G., Pagnini, I., Wright, T. B., Beukelman, T., . . . Weiss, P. F. (2017). Multicenter inception cohort of enthesitis-related arthritis: Variation in disease characteristics and treatment approaches. Arthritis Research and Therapy, 19(1), 10 pages. Scopus56 WoS55 Europe PMC42 |
| 2017 | Beukelman, T., Anink, J., Berntson, L., Duffy, C., Ellis, J. A., Glerup, M., . . . Hyrich, K. (2017). A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: Challenges and opportunities. Pediatric Rheumatology, 15(1), 9 pages. Scopus26 WoS23 Europe PMC20 |
| 2017 | Beukelman, T., Kimura, Y., Ilowite, N. T., Mieszkalski, K., Natter, M. D., Burrell, G., . . . Swann, S. (2017). The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: Design, rationale, and characteristics of patients enrolled in the first 12months. Pediatric Rheumatology, 15(1), 10 pages. Scopus102 WoS94 Europe PMC84 |
| 2017 | Kimura, Y., Grevich, S., Beukelman, T., Morgan, E., Nigrovic, P. A., Mieszkalski, K., . . . Rossette, J. (2017). Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans. Pediatric Rheumatology, 15(1), 8 pages. Scopus43 WoS41 Europe PMC38 |
| 2017 | Horton, D. B., Onel, K. B., Beukelman, T., & Ringold, S. (2017). Attitudes and approaches for withdrawing drugs for children with clinically inactive nonsystemic JIA: A survey of the childhood arthritis and rheumatology research alliance. Journal of Rheumatology, 44(3), 352-360. Scopus44 WoS37 Europe PMC31 |
| 2017 | Phillippi, K., Hoeltzel, M., Byun Robinson, A., Kim, S., Abramson, L. S., Anderson, E. S., . . . Zemel, L. S. (2017). Race, Income, and Disease Outcomes in Juvenile Dermatomyositis. Journal of Pediatrics, 184, 38-44.e1. Scopus65 Europe PMC53 |
| 2016 | Curtis, J. R., Xie, F., MacKey, D., Gerber, N., Bharat, A., Beukelman, T., . . . Ginsberg, S. (2016). Patient's experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis. BMC Musculoskeletal Disorders, 17(1), 11 pages. Scopus25 WoS24 Europe PMC20 |
| 2016 | Luca, N. J., Burnett, H. F., Ungar, W. J., Moretti, M. E., Beukelman, T., Feldman, B. M., . . . Bayoumi, A. M. (2016). Cost-Effectiveness Analysis of First-Line Treatment With Biologic Agents in Polyarticular Juvenile Idiopathic Arthritis. Arthritis Care and Research, 68(12), 1803-1811. Scopus18 WoS14 Europe PMC11 |
| 2016 | Beukelman, T., Xie, F., Baddley, J. W., Chen, L., Mannion, M. L., Saag, K. G., . . . Curtis, J. R. (2016). The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis. Arthritis Research and Therapy, 18(1), 9 pages. Scopus40 WoS37 Europe PMC30 |
| 2016 | Mannion, M. L., Xie, F., Baddley, J., Chen, L., Curtis, J. R., Saag, K., . . . Beukelman, T. (2016). Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patients. Pediatric Rheumatology, 14(1), 6 pages. Scopus23 WoS21 Europe PMC16 |
| 2016 | Zhang, M., Bracaglia, C., Prencipe, G., Bemrich-Stolz, C. J., Beukelman, T., Dimmitt, R. A., . . . Cron, R. Q. (2016). A heterozygous RAB27A mutation associated with delayed cytolytic granule polarization and hemophagocytic lymphohistiocytosis. Journal of Immunology, 196(6), 2492-2503. Scopus84 WoS90 Europe PMC70 |
| 2016 | Scott, F. I., Mamtani, R., Brensinger, C. M., Haynes, K., Chiesa-Fuxench, Z. C., Zhang, J., . . . Lewis, J. D. (2016). Risk of nonmelanoma skin cancer associated with the use of immunosuppressant and biologic agents in patients with a history of autoimmune disease and nonmelanoma skin cancer. JAMA Dermatology, 152(2), 164-172. Scopus164 WoS147 Europe PMC119 |
| 2016 | Yun, H., Xie, F., Delzell, E., Levitan, E. B., Chen, L., Lewis, J. D., . . . Curtis, J. R. (2016). Comparative Risk of Hospitalized Infection Associated with Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare. Arthritis and Rheumatology, 68(1), 56-66. Scopus151 WoS134 Europe PMC110 |
| 2016 | Janow, G., Schanberg, L. E., Setoguchi, S., Hasselblad, V., Mellins, E. D., Schneider, R., . . . Thomas, E. (2016). The systemic juvenile idiopathic arthritis cohort of the childhood arthritis and rheumatology research alliance registry: 2010-2013. Journal of Rheumatology, 43(9), 1755-1762. Scopus49 Europe PMC43 |
| 2016 | Prahalad, S., McCracken, C. E., Ponder, L. A., Angeles-Han, S. T., Rouster Stevens, K. A., Vogler, L. B., . . . Schikler, K. (2016). Familial autoimmunity in the childhood arthritis and rheumatology research alliance registry. Pediatric Rheumatology, 14(1), 14. Scopus21 Europe PMC16 |
| 2015 | Stoll, M. L., Vaid, Y. N., Guleria, S., Beukelman, T., Waite, P. D., & Cron, R. Q. (2015). Magnetic resonance imaging findings following intraarticular infliximab therapy for refractory temporomandibular joint arthritis among children with juvenile idiopathic arthritis. Journal of Rheumatology, 42(11), 2155-2159. Scopus20 WoS19 Europe PMC13 |
| 2015 | Zhang, J., Xie, F., Delzell, E., Yun, H., Lewis, J. D., Haynes, K., . . . Curtis, J. R. (2015). Impact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients. Arthritis Care and Research, 67(5), 624-632. Scopus41 WoS43 Europe PMC37 |
| 2015 | Yun, H., Xie, F., Delzell, E., Chen, L., Levitan, E. B., Lewis, J. D., . . . Curtis, J. R. (2015). Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy. Arthritis Care and Research, 67(5), 731-736. Scopus109 WoS94 Europe PMC85 |
| 2015 | Yun, H., Xie, F., Delzell, E., Chen, L., Levitan, E. B., Lewis, J. D., . . . Kvien, T. K. (2015). Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy. Annals of the Rheumatic Diseases, 74(6), 1065-1071. Scopus86 WoS77 Europe PMC69 |
| 2015 | Tambralli, A., Beukelman, T., Cron, R. Q., & Stoll, M. L. (2015). Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseases. Journal of Rheumatology, 42(3), 541-546. Scopus58 WoS40 Europe PMC39 |
| 2015 | Ringold, S., Hendrickson, A., Abramson, L., Beukelman, T., Blier, P. R., Bohnsack, J., . . . Sobel, R. E. (2015). Novel method to collect medication adverse events in juvenile arthritis: Results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance project. Arthritis Care and Research, 67(4), 529-537. Scopus9 WoS7 Europe PMC3 |
| 2014 | Beukelman, T. (2014). Treatment advances in systemic juvenile idiopathic arthritis. F1000prime Reports, 6, 21. Scopus33 Europe PMC30 |
| 2014 | Curtis, J. R., Zhang, J., Xie, F., Beukelman, T., Chen, L., Fernandes, J., . . . Schiff, M. (2014). Use of Oral and Subcutaneous Methotrexate in Rheumatoid Arthritis Patients in the United States. Arthritis Care and Research, 66(11), 1604-1611. Scopus38 WoS39 Europe PMC33 |
| 2014 | Mannion, M. L., & Beukelman, T. (2014). Risk of malignancy associated with biologic agents in pediatric rheumatic disease. Current Opinion in Rheumatology, 26(5), 538-542. Scopus19 WoS15 Europe PMC9 |
| 2014 | Weiss, P. F., Colbert, R. A., Xiao, R., Feudtner, C., Beukelman, T., Dewitt, E. M., . . . Wallace, C. A. (2014). Development and retrospective validation of the juvenile spondyloarthritis disease activity index. Arthritis Care and Research, 66(12), 1775-1782. Scopus83 WoS85 Europe PMC62 |
| 2014 | Mannion, M. L., Xie, F., Curtis, J. R., & Beukelman, T. (2014). Recent trends in medication usage for the treatment of juvenile idiopathic arthritis and the influence of tumor necrosis factor inhibitors. Journal of Rheumatology, 41(10), 2078-2084. Scopus19 WoS16 Europe PMC14 |
| 2014 | Baddley, J. W., Winthrop, K. L., Chen, L., Liu, L., Grijalva, C. G., Delzell, E., . . . Curtis, J. R. (2014). Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: Results of the SAfety assessment of biologic ThERapy (SABER) study. Annals of the Rheumatic Diseases, 73(11), 1942-1948. Scopus100 WoS95 Europe PMC79 |
| 2014 | Kimura, Y., Morgan Dewitt, E., Beukelman, T., Stoll, M. L., Nigrovic, P. A., Onel, K., . . . Schneider, R. (2014). Adding canakinumab to the childhood arthritis and rheumatology research alliance consensus treatment plans for systemic juvenile idiopathic arthritis: Comment on the article by DeWitt et al. Arthritis Care and Research, 66(9), 1430-1431. Scopus28 WoS20 Europe PMC19 |
| 2014 | Shafferman, A., Fontaine, K. R., Cron, R. Q., & Beukelman, T. (2014). Changes in body mass index in children with juvenile idiopathic arthritis treated with tumor necrosis factor inhibitors. Journal of Rheumatology, 41(1), 113-118. Scopus9 WoS9 Europe PMC8 |
| 2014 | Vaid, Y. N., Daniel Dunnavant, F., Royal, S. A., Beukelman, T., Stoll, M. L., & Cron, R. Q. (2014). Imaging of the temporomandibular joint in juvenile idiopathic arthritis. Arthritis Care and Research, 66(1), 47-54. Scopus70 WoS64 Europe PMC46 |
| 2013 | Hurd, A., & Beukelman, T. (2013). Infectious complications in juvenile idiopathic arthritis. Current Rheumatology Reports, 15(5), 7 pages. Scopus33 WoS23 Europe PMC16 |
| 2013 | Mannion, M. L., & Beukelman, T. (2013). What is the background incidence of malignancy in children with rheumatic disease?. Current Rheumatology Reports, 15(3), 6 pages. Scopus22 WoS21 Europe PMC14 |
| 2013 | Tambralli, A., Beukelman, T., Weiser, P., Atkinson, T. P., Cron, R. Q., & Stoll, M. L. (2013). High doses of infliximab in the management of juvenile idiopathic arthritis. Journal of Rheumatology, 40(10), 1749-1755. Scopus57 WoS45 Europe PMC37 |
| 2013 | Lionetti, G., Kimura, Y., Schanberg, L. E., Beukelman, T., Wallace, C. A., Ilowite, N. T., . . . Sandborg, C. I. (2013). Using registries to identify adverse events in rheumatic diseases. Pediatrics, 132(5), e1384-e1394. Scopus24 WoS19 Europe PMC18 |
| 2013 | Ringold, S., Weiss, P. F., Beukelman, T., Dewitt, E. M., Ilowite, N. T., Kimura, Y., . . . Vehe, R. K. (2013). 2013 Update of the 2011 American College of Rheumatology Recommendations for the treatment of juvenile idiopathic arthritis: Recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis and Rheumatism, 65(10), 2499-2512. Scopus244 WoS194 Europe PMC160 |
| 2013 | Ringold, S., Weiss, P. F., Beukelman, T., Dewitt, E. M., Ilowite, N. T., Kimura, Y., . . . Vehe, R. K. (2013). 2013 Update of the 2011 American college of rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Care and Research, 65(10), 1551-1563. Scopus101 WoS72 Europe PMC63 |
| 2013 | Ringold, S., Beukelman, T., Nigrovic, P. A., & Kimura, Y. (2013). Race, ethnicity, and disease outcomes in juvenile idiopathic arthritis: A cross-sectional analysis of the childhood arthritis and rheumatology research alliance (CARRA) registry. Journal of Rheumatology, 40(6), 936-942. Scopus47 WoS46 Europe PMC46 |
| 2013 | Donnithorne, K. J., Read, R. W., Lowe, R., Weiser, P., Cron, R. Q., & Beukelman, T. (2013). Retinal vasculitis in two pediatric patients with systemic lupus erythematosus: A case report. Pediatric Rheumatology, 11(1), 6 pages. Scopus34 WoS31 Europe PMC26 |
| 2013 | Beukelman, T., Xie, F., Baddley, J. W., Chen, L., Delzell, E., Grijalva, C. G., . . . Curtis, J. R. (2013). Brief report: Incidence of selected opportunistic infections among children with juvenile idiopathic arthritis. Arthritis and Rheumatism, 65(5), 1384-1389. Scopus61 WoS54 Europe PMC45 |
| 2013 | Winthrop, K. L., Baddley, J. W., Chen, L., Liu, L., Grijalva, C. G., Delzell, E., . . . Curtis, J. R. (2013). Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster. JAMA, 309(9), 887-895. Scopus192 WoS162 Europe PMC142 |
| 2013 | Winthrop, K. L., Chen, L., Fraunfelder, F. W., Ku, J. H., Varley, C. D., Suhler, E., . . . Curtis, J. R. (2013). Initiation of anti-TNF therapy and the risk of optic neuritis: From the safety assessment of biologic ThERapy (SABER) study. American Journal of Ophthalmology, 155(1), 183-189.e1. Scopus70 WoS53 Europe PMC46 |
| 2013 | Haynes, K., Beukelman, T., Curtis, J. R., Newcomb, C., Herrinton, L. J., Graham, D. J., . . . Lewis, J. D. (2013). Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases. Arthritis and Rheumatism, 65(1), 48-58. Scopus129 WoS118 Europe PMC102 |
| 2012 | Woolston, S. L., Beukelman, T., & Sherry, D. D. (2012). Back mobility and interincisor distance ranges in racially diverse North American healthy children and relationship to generalized hypermobility. Pediatric Rheumatology, 10(1), 5 pages. Scopus12 WoS10 Europe PMC9 |
| 2012 | Beukelman, T., Ringold, S., Davis, T. E., Morgan DeWitt, E., Pelajo, C. F., Weiss, P. F., & Kimura, Y. (2012). Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: A cross-sectional analysis of the CARRA registry. Journal of Rheumatology, 39(9), 1867-1874. Scopus78 WoS65 Europe PMC56 |
| 2012 | Weiss, P. F., Beukelman, T., Schanberg, L. E., Kimura, Y., & Colbert, R. A. (2012). Enthesitis-related arthritis is associated with higher pain intensity and poorer health status in comparison with other categories of juvenile idiopathic arthritis: The Childhood Arthritis and Rheumatology Research Alliance Registry. Journal of Rheumatology, 39(12), 2341-2351. Scopus91 WoS85 Europe PMC77 |
| 2012 | Saag, K. G., Mohr, P. E., Esmail, L., Mudano, A. S., Wright, N., Beukelman, T., . . . Tunis, S. R. (2012). Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States. Contemporary Clinical Trials, 33(6), 1211-1216. Scopus24 WoS19 Europe PMC19 |
| 2012 | Curtis, J. R., Xie, F., Chen, L., Muntner, P., Grijalva, C. G., Spettell, C., . . . Delzell, E. (2012). Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high-versus lower-risk rheumatoid arthritis patients. Arthritis Care and Research, 64(10), 1480-1489. Scopus52 WoS48 Europe PMC42 |
| 2012 | Stoll, M. L., Sharpe, T., Beukelman, T., Good, J., Young, D., & Cron, R. Q. (2012). Risk factors for temporomandibular joint arthritis in children with juvenile idiopathic arthritis. Journal of Rheumatology, 39(9), 1880-1887. Scopus121 WoS115 Europe PMC93 |
| 2012 | Stoll, M. L., Good, J., Sharpe, T., Beukelman, T., Young, D., Waite, P. D., & Cron, R. Q. (2012). Intra-articular corticosteroid injections to the temporomandibular joints are safe and appear to be effective therapy in children with juvenile idiopathic arthritis. Journal of Oral and Maxillofacial Surgery, 70(8), 1802-1807. Scopus76 WoS75 Europe PMC60 |
| 2012 | Beukelman, T., Xie, F., Chen, L., Baddley, J. W., Delzell, E., Grijalva, C. G., . . . Curtis, J. R. (2012). Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis and Rheumatism, 64(8), 2773-2780. Scopus164 WoS142 Europe PMC125 |
| 2012 | Dewitt, E. M., Kimura, Y., Beukelman, T., Nigrovic, P. A., Onel, K., Prahalad, S., . . . Wallace, C. A. (2012). Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. Arthritis Care and Research, 64(7), 1001-1010. Scopus217 WoS183 Europe PMC161 |
| 2012 | Singh, J. A., Furst, D. E., Bharat, A., Curtis, J. R., Kavanaugh, A. F., Kremer, J. M., . . . Saag, K. G. (2012). 2012 update of the 2008 American college of rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care and Research, 64(5), 625-639. Scopus1474 WoS1280 Europe PMC1108 |
| 2012 | Beukelman, T., Haynes, K., Curtis, J. R., Xie, F., Chen, L., Bemrich-Stolz, C. J., . . . Safety Assessment of Biological Therapeutics Collaboration. (2012). Rates of malignancy associated with juvenile idiopathic arthritis and its treatment.. Arthritis and Rheumatism, 64(4), 1263-1271. Scopus147 WoS123 Europe PMC106 |
| 2012 | Bharat, A., Xie, F., Baddley, J. W., Beukelman, T., Chen, L., Calabrese, L., . . . Curtis, J. R. (2012). Incidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseases. Arthritis Care and Research, 64(4), 612-615. Scopus54 WoS41 Europe PMC36 |
| 2012 | Mannion, M., Zolak, M., Kelly, D. R., Beukelman, T., & Cron, R. Q. (2012). Sarcoidosis in a young child with Alagille syndrome: a case report. PEDIATRIC RHEUMATOLOGY, 10(1), 6 pages. WoS2 |
| 2011 | Donnithorne, K. J., Cron, R. Q., & Beukelman, T. (2011). Attainment of inactive disease status following initiation of TNF-α inhibitor therapy for juvenile idiopathic arthritis: Enthesitis-related arthritis predicts persistent active disease. Journal of Rheumatology, 38(12), 2675-2681. Scopus49 WoS46 Europe PMC43 |
| 2011 | Record, J. L., Beukelman, T., & Cron, R. Q. (2011). High prevalence of myositis in a southeastern United States pediatric systemic lupus erythematosus cohort. Pediatric Rheumatology, 9(1), 6 pages. Scopus14 WoS11 Europe PMC8 |
| 2011 | Record, J. L., Beukelman, T., & Cron, R. Q. (2011). Combination therapy of abatacept and in children with refractory systemic juvenile idiopathic arthritis: A retrospective case series. Journal of Rheumatology, 38(1), 180-181. Scopus74 WoS61 Europe PMC53 |
| 2011 | Baddley, J. W., Winthrop, K. L., Patkar, N. M., Delzell, E., Beukelman, T., Xie, F., . . . Curtis, J. R. (2011). Geographic distribution of endemic fungal infections among older persons, United States. Emerging Infectious Diseases, 17(9), 1664-1669. Scopus169 WoS139 Europe PMC119 |
| 2011 | Curtis, J. R., Xie, F., Chen, L., Baddley, J. W., Beukelman, T., Saag, K. G., . . . Delzell, E. (2011). The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents. Annals of the Rheumatic Diseases, 70(8), 1401-1406. Scopus108 WoS98 Europe PMC78 |
| 2011 | Grijalva, C. G., Chen, L., Delzell, E., Baddley, J. W., Beukelman, T., Winthrop, K. L., . . . Curtis, J. R. (2011). Initiation of tumor necrosis factor-αantagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA, 306(21), 2331-2339. Scopus340 WoS309 Europe PMC277 |
| 2011 | Herrinton, L. J., Curtis, J. R., Chen, L., Liu, L., Delzell, E., Lewis, J. D., . . . Saag, K. G. (2011). Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems. Pharmacoepidemiology and Drug Safety, 20(11), 1199-1209. Scopus26 WoS25 Europe PMC27 |
| 2011 | Fain, E. T., Atkinson, G. P., Weiser, P., Beukelman, T., & Cron, R. Q. (2011). Temporomandibular joint arthritis in pediatric Sjögren disease and sarcoidosis. Journal of Rheumatology, 38(10), 2272-2273. Scopus9 WoS9 Europe PMC2 |
| 2011 | Ashraf, A. P., Beukelman, T., Pruneta-Deloche, V., Kelly, D. R., & Garg, A. (2011). Type 1 hyperlipoproteinemia and recurrent acute pancreatitis due to lipoprotein lipase antibody in a young girl with Sjögren's syndrome. Journal of Clinical Endocrinology and Metabolism, 96(11), 3302-3307. Scopus28 WoS26 Europe PMC22 |
| 2011 | Lovell, D. J., Henrickson, M., Dewitt, E. M., Segerman, J., Taylor, J., Giannini, E. H., . . . Vehe, R. K. (2011). Reply. Arthritis Care and Research, 63(9), 1353. |
| 2011 | Beukelman, T., Cron, R. Q., Patkar, N. M., Saag, K. G., Dewitt, E. M., Lovell, D. J., . . . Rabinovich, C. E. (2011). Reply. Arthritis Care and Research, 63(9), 1355. Scopus4 WoS4 |
| 2011 | Beukelman, T., Patkar, N. M., Saag, K. G., Tolleson-Rinehart, S., Cron, R. Q., DeWitt, E. M., . . . Ruperto, N. (2011). 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.. Arthritis Care Research, 63(4), 465-482. Scopus747 WoS609 Europe PMC505 |
| 2011 | Lovell, D. J., Passo, M. H., Beukelman, T., Bowyer, S. L., Gottlieb, B. S., Henrickson, M., . . . Giannini, E. H. (2011). Measuring process of arthritis care: A proposed set of quality measures for the process of care in juvenile idiopathic arthritis. Arthritis Care and Research, 63(1), 10-16. Scopus61 WoS62 Europe PMC51 |
| 2010 | Cron, R. Q., & Beukelman, T. (2010). Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?. Pediatric Rheumatology, 8(1), 3 pages. Scopus30 WoS25 Europe PMC25 |
| 2010 | Curtis, J. R., Beukelman, T., Onofrei, A., Cassell, S., Greenberg, J. D., Kavanaugh, A., . . . Kremer, J. M. (2010). Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide. Annals of the Rheumatic Diseases, 69(1), 43-47. Scopus220 WoS190 Europe PMC151 |
| 2010 | Beukelman, T., Saag, K. G., Curtis, J. R., Kilgore, M. L., & Pisu, M. (2010). Cost-effectiveness of multifaceted evidence implementation programs for the prevention of glucocorticoid-induced osteoporosis. Osteoporosis International, 21(9), 1573-1584. Scopus17 WoS14 Europe PMC11 |
| 2010 | Mehta, J., Genin, A., Brunner, M., Scalzi, L. V., Mishra, N., Beukelman, T., & Cron, R. Q. (2010). Prolonged expression of CD154 on CD4 T cells from pediatric lupus patients correlates with increased CD154 transcription, increased nuclear factor of activated T cell activity, and glomerulonephritis. Arthritis and Rheumatism, 62(8), 2499-2509. Scopus18 WoS20 Europe PMC17 |
| 2009 | Donnithorne, K. J., Atkinson, T. P., Hinze, C. H., Nogueira, J. B., Saeed, S. A., Askenazi, D. J., . . . Cron, R. Q. (2009). Rituximab Therapy for Severe Refractory Chronic Henoch-Schönlein Purpura. Journal of Pediatrics, 155(1), 136-139. Scopus70 WoS50 Europe PMC40 |
| 2008 | Beukelman, T., Guevara, J. P., & Albert, D. A. (2008). Optimal treatment of knee monarthritis in juvenile idiopathic arthritis: A decision analysis. Arthritis Care and Research, 59(11), 1580-1588. Scopus26 WoS17 Europe PMC16 |
| 2008 | Beukelman, T., Guevara, J. P., Albert, D. A., Sherry, D. D., & Burnham, J. M. (2008). Usage of intra-articular corticosteroid injections for the treatment of juvenile idiopathic arthritis: A survey of pediatric rheumatologists in the United States and Canada. Clinical and Experimental Rheumatology, 26(4), 700-703. Scopus22 WoS20 Europe PMC16 |
| 2008 | Behrens, E. M., Beukelman, T., Gallo, L., Spangler, J., Rosenkranz, M., Arkachaisri, T., . . . Cron, R. Q. (2008). Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: Data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). Journal of Rheumatology, 35(2), 343-348. Scopus167 WoS133 Europe PMC95 |
| 2007 | Behrens, E. M., Beukelman, T., & Cron, R. Q. (2007). Juvenile idiopathic arthritis classification criteria: Loopholes and diagnosis software [3]. Journal of Rheumatology, 34(1), 234. Scopus15 WoS10 Europe PMC8 |
| 2007 | Beukelman, T., Guevara, J. P., Albert, D. A., Sherry, D. D., & Burnham, J. M. (2007). Variation in the initial treatment of knee monoarthritis in juvenile idiopathic arthritis: A survey of pediatric rheumatologists in the United States and Canada. Journal of Rheumatology, 34(9), 1918-1924. Scopus23 WoS22 Europe PMC19 |
| 2007 | Behrens, E. M., Beukelman, T., Paessler, M., & Cron, R. Q. (2007). Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. Journal of Rheumatology, 34(5), 1133-1138. Scopus339 WoS303 Europe PMC256 |
| 2007 | Cahill, A. M., Cho, S. S., Baskin, K. M., Beukelman, T., Cron, R. Q., Kaye, R. D., & Towbin, R. B. (2007). Benefit of fluoroscopically guided intraarticular, long-acting corticosteroid injection for subtalar arthritis in juvenile idiopathic arthritis. Pediatric Radiology, 37(6), 544-548. Scopus39 WoS26 Europe PMC23 |
| 2006 | Beukelman, T., Arabshahi, B., Cahill, A. M., Kaye, R. D., & Cron, R. Q. (2006). Benefit of intraarticular corticosteroid injection under fluoroscopic guidance for subtalar arthritis in juvenile idiopathic arthritis. Journal of Rheumatology, 33(11), 2330-2336. Scopus34 WoS28 Europe PMC22 |
| Year | Citation |
|---|---|
| 2026 | Beukelman, T., & Feldman, B. (2026). Understanding Clinical Investigations. In R. E. Petty, R. M. Laxer, L. R. Wedderburn, E. D. Mellins, R. C. Fuhlbrigge, J. D. Akikusa, & H. I. Brunner (Eds.), Textbook of Pediatric Rheumatology (pp. 71-88). Elsevier Health Sciences. |
| 2022 | Cron, R. Q., Weiser, P., & Beukelman, T. (2022). Juvenile Idiopathic Arthritis. In Clinical Immunology Principles and Practice Sixth Edition (pp. 693-703). Elsevier. DOI |
| 2019 | Cron, R. Q., Weiser, P., & Beukelman, T. (2019). Juvenile Idiopathic Arthritis. In Clinical Immunology Principles and Practice (pp. 723-733.e1). Elsevier. DOI Scopus1 |
| 2015 | Beukelman, T., & Brunner, H. I. (2015). Trial Design, Measurement, and Analysis of Clinical Investigations. In Textbook of Pediatric Rheumatology (pp. 54-77). Elsevier. DOI Scopus15 |
| 2013 | Cron, R. Q., Weiser, P., & Beukelman, T. (2013). Juvenile idiopathic arthritis. In Clinical Immunology Principles and Practice Fourth Edition (pp. 637-647). Elsevier. DOI Scopus4 |
| Year | Citation |
|---|---|
| 2026 | Horton, D., Li, Y., Nyandege, A., Liu, N., Luo, L., Beukelman, T., . . . Hu, L. (2026). Adalimumab Tapering is Associated with Short-term, but not Long-term, Advantages for Well-controlled Juvenile Idiopathic Arthritis: A Retrospective Cohort Study using the CARRA Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 78 (pp. 260-262). WILEY. |
| 2025 | George, M., Riley, T., Romich, E., Holladay, E., Beukelman, T., Daigle, S., . . . Curtis, J. (2025). Comparing characteristics, diagnostics, and treatment in people with different idiopathic inflammatory myopathies using a large representative cohort. In ARTHRITIS & RHEUMATOLOGY Vol. 77 (pp. 3990-3992). WILEY. |
| 2024 | Sattui, S. E., Buttgereit, F., Lidar, M., Ford, K., Fiore, S., Araujo, L., . . . Curtis, J. (2024). PREVALENCE AND MANAGEMENT OF PATIENTS WITH COMORBIDITIES AND FRAILTY IN NEW ONSET POLYMYALGIA RHEUMATICA. In ANNALS OF THE RHEUMATIC DISEASES Vol. 83 (pp. 1187-1188). AUSTRIA, Vienna: ELSEVIER. DOI WoS2 |
| 2024 | Wang, L., Gandhi, S., Dennos, A., Mundayat, R., Diehl, A., Vranic, I., . . . Beukelman, T. (2024). Safety Events in Patients with Polyarticular-Course Juvenile Idiopathic Arthritis Exposed to Tofacitinib (Xeljanz) or Biologics: Real-World Data from the CARRA Registry. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 33 (pp. 159-160). WILEY. |
| 2024 | Curtis, J. R., Dua, A., Rubbert-Roth, A., Ford, K., Fiore, S., Araujo, L., . . . Xie, F. (2024). Characteristics Associated with Long-Term Glucocorticoid Use in Patients with New Onset Polymyalgia Rheumatica. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 33 (pp. 214-215). WILEY. |
| 2024 | Glaser, D., Yildirim-Toruner, C., Tarvin, S., Ardoin, S., & Beukelman, T. (2024). Variability of Data Completeness and Consensus Treatment Plan Adherence for Polyarticular Juvenile Idiopathic Arthritis Patients Within the Childhood Arthritis and Rheumatology Research Alliance Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 76 (pp. 765-767). WILEY. |
| 2024 | Dua, A., Rubbert-Roth, A., Ford, K., Fiore, S., Araujo, L., Beukelman, T., . . . Curtis, J. (2024). Characteristics Associated with Long-Term Glucocorticoids Use in Patients with New Onset Polymyalgia Rheumatica. In ARTHRITIS & RHEUMATOLOGY Vol. 76 (pp. 1578-1581). WILEY. |
| 2024 | Sattui, S. E., Buttgereit, F. H. D. R., Lidar, M., Ford, K., Fiore, S., Araujo, L., . . . Curtis, J. (2024). Prevalence and Management of Patients with Comorbidities and Frailty in New Onset Polymyalgia Rheumatica. In ARTHRITIS & RHEUMATOLOGY Vol. 76 (pp. 2006-2008). WILEY. |
| 2024 | Hahn, T., Tomlinson, G., Kimura, Y., Del Gaizo, V., Valdes, C., & Beukelman, T. (2024). Two- and 3-Year Outcomes of the Childhood Arthritis and Rheumatology Research Alliance FROST Study of New-onset Systemic JIA Treatment. In ARTHRITIS & RHEUMATOLOGY Vol. 76 (pp. 754-756). WILEY. |
| 2024 | Dua, A. B., Rubbert-Roth, A., Ford, K., Fiore, S., Araujo, L., Beukelman, T., . . . Curtis, J. R. (2024). CHARACTERISTICS ASSOCIATED WITH LONG-TERM GLUCOCORTICOIDS USE IN PATIENTS WITH NEW ONSET POLYMYALGIA RHEUMATICA. In ANNALS OF THE RHEUMATIC DISEASES Vol. 83 (pp. 2 pages). AUSTRIA, Vienna: ELSEVIER. DOI |
| 2023 | Titievsky, L., Manjelievskaia, J., Ender, K. L., Shi, D., Lillehaugen, T., & Beukelman, T. (2023). Frequency of vaso-occlusive crises among patients with severe sickle cell disease receiving standard-of-care treatment. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 32 (pp. 85). WILEY. |
| 2023 | Yildirim-Toruner, C., Glaser, D., Beukelman, T., Ardoin, S., Hashmi, A., Pooni, R., . . . Tarvin, S. (2023). Assessment of Barriers and Facilitators in Implementation of the Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans. In ARTHRITIS & RHEUMATOLOGY Vol. 75 (pp. 119-121). LA, New Orleans: WILEY. |
| 2022 | James, K., Tomlinson, G., Beukelman, T., Schanberg, L., Dennos, A., Del Gaizo, V., . . . Kimura, Y. (2022). Effect of Glucocorticoids on Patient Reported Outcomes in Patients Started on a Biologic Consensus Treatment Plan for the. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 1705-1708). PA, Philadelphia: WILEY. |
| 2022 | Mannion, M., Xie, F., Beukelman, T., & Curtis, J. (2022). Change in Short Term Outcomes Following Tolerated Disease Activity Level for Individuals with Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 1687-1689). PA, Philadelphia: WILEY. |
| 2022 | Mannion, M., Amin, S., Balevic, S., Correll, C., & Beukelman, T. (2022). Outcomes of Patients with Juvenile Idiopathic Arthritis Following Failure of Initial Tumor Necrosis Factor Inhibitor Medication in the Childhood Arthritis and Rheumatology Research Alliance Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 1678-1680). PA, Philadelphia: WILEY. |
| 2022 | Correll, C., Stryker, S., Collier, D., Dennos, A., Balevic, S., Phillips, T., & Beukelman, T. (2022). Change in Disease Activity and Occurrence of Adverse Events After Initiation of Etanercept in Pediatric Patients with Juvenile Psoriatic Arthritis in the CARRA Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 2794-2795). PA, Philadelphia: WILEY. |
| 2022 | Mannion, M. L., Xie, F., Beukelman, T., & Curtis, J. (2022). Tolerated juvenile idiopathic arthritis disease activity states in the childhood arthritis and rheumatology research alliance registry. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 31 (pp. 572). WILEY. |
| 2021 | Beukelman, T., Tomlinson, G., Nigrovic, P., Dennos, A., Del Gaizo, V., Riordan, M. E., . . . Kimura, Y. (2021). FiRst Line Options for Systemic JIA Treatment (FROST): Results from a Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry Consensus Treatment Plan Observational Study. In ARTHRITIS & RHEUMATOLOGY Vol. 73 (pp. 485-487). ELECTR NETWORK: WILEY. |
| 2021 | Twilt, M., Baszis, K., Ringold, S., Beukelman, T., Dennos, A., Shrader, P., & Horton, D. (2021). Methotrexate Withdrawal and Outcomes in Participants with Well-controlled Non-systemic JIA Within the CARRA Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 73 (pp. 532-535). ELECTR NETWORK: WILEY. |
| 2021 | Mannion, M., Xie, F., Beukelman, T., & Curtis, J. (2021). Identification of Tolerated Disease Activity Level for Individuals with Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 73 (pp. 518-520). ELECTR NETWORK: WILEY. |
| 2021 | Zhao, Y., Sullivan, E., Son, M. B., & Beukelman, T. (2021). Psoriasis Rate Is Increased by the Exposure to TNF Inhibition in Children with JIA. In ARTHRITIS & RHEUMATOLOGY Vol. 73 (pp. 483-485). ELECTR NETWORK: WILEY. |
| 2020 | Verstegen, R., Shrader, P., Balevic, S., Beukelman, T., Correll, C., Dennos, A., . . . Feldman, B. (2020). Variations in Adalimumab and Etanercept Dosing in Juvenile Idiopathic Arthritis and Their Effect on Treatment Outcome: A Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry Study. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 3 pages). ELECTR NETWORK: WILEY. WoS1 |
| 2020 | Gabbeta, A., Mulvihill, E., Beukelman, T., Lewis, J., Rose, C., Strom, B., & Horton, D. (2020). Validation of New Antirheumatic Drug Use as a Proxy for Increased JIA Disease Activity. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 3 pages). ELECTR NETWORK: WILEY. |
| 2020 | Shiff, N., Shrader, P., Correll, C., Dennos, A., Phillips, T., & Beukelman, T. (2020). Trajectories of Disease Activity in Patients with Newly Diagnosed Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 3 pages). ELECTR NETWORK: WILEY. |
| 2020 | Correll, C., Shrader, P., Dennos, A., Phillips, T., Shiff, N., Verstegen, R., & Beukelman, T. (2020). Alternative Dosing of Biologic Therapies Is Frequent Among Children with Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 2 pages). ELECTR NETWORK: WILEY. |
| 2020 | Janow, G., Beukelman, T., Kimura, Y., Schneider, R., Mohan, S., Rodich, G., & Son, M. B. (2020). Trends in Timing of Biologic Use for Treatment of Systemic Juvenile Idiopathic Arthritis in the CARRA Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 4 pages). ELECTR NETWORK: WILEY. |
| 2020 | Smitherman, E., Chahine, R., Beukelman, T., Knight, A., Rahman, A. K. M., Son, M. B., . . . Hersh, A. (2020). Sociodemographic and Clinical Predictors of Childhood-Onset SLE Disease Activity in the Childhood Arthritis and Rheumatology Research Alliance Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 4 pages). ELECTR NETWORK: WILEY. |
| 2020 | Horton, D. B., Salas, J., Wec, A., Kapadia, P., Beukelman, T., Boneparth, A. D., . . . Rosenthal, M. (2020). Stopping medicines for inactive juvenile idiopathic arthritis: What do patients and families consider?. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 29 (pp. 458-459). WILEY. |
| 2020 | Zhao, Y., Beukelman, T., Kimura, Y., Becker, M., Ringold, S., Dennos, A., & Schanberg, L. (2020). Patients with Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: Clinical Characteristics and Inception Cohorts. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 82-83). LA, New Orleans: WILEY. WoS2 |
| 2020 | Rumsey, D., Lougee, A., Matsouaka, R., Collier, D., Schanberg, L., Schenfeld, J., . . . Beukelman, T. (2020). Juvenile Spondyloarthritis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: High Biologic Use, Low Prevalence of HLA-B27, and Equal Sex Representation in Those with Sacroiliitis. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 211-213). LA, New Orleans: WILEY. |
| 2020 | Smitherman, E., Chahine, R., Beukelman, T., Lewandowski, L., Rahman, A. K. M. F., Wenderfer, S., . . . Curtis, J. R. (2020). Disease Characteristics and Medication Utilization in Lupus Nephritis Associated with Childhood-Onset Systemic Lupus Erythematosus. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 217-220). LA, New Orleans: WILEY. |
| 2020 | Shiff, N., Lougee, A., Matsouaka, R., Collier, D., Kimura, Y., Rumsey, D., . . . Beukelman, T. (2020). Patterns of Etanercept Use in the Childhood Arthritis and Rheumatology Research Alliance Juvenile Idiopathic Arthritis Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 200-202). LA, New Orleans: WILEY. |
| 2020 | Ardoin, S., Balevic, S., Hersh, A., Kimura, Y., Knight, A., Schanberg, L., . . . Beukelman, T. (2020). The Childhood and Rheumatology Research Alliance Systemic Lupus Erythematosus and Related Disorders Cohort. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 60-62). LA, New Orleans: WILEY. |
| 2020 | Janow, G., Beukelman, T., Kimura, Y., Schneider, R., Mohan, S., Rodich, G., & Son, M. B. (2020). Treatment of Systemic Juvenile Idiopathic Arthritis in the CARRA Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 165-167). LA, New Orleans: WILEY. |
| 2020 | Smitherman, E., Chahine, R., Beukelman, T., Knight, A., Rahman, A. K. M. F., Son, M. B., . . . Hersh, A. (2020). Predictors of Moderate/High Disease Activity in Childhood-Onset Systemic Lupus Erythematosus. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 220-222). LA, New Orleans: WILEY. |
| 2020 | Son, M. B., Kimura, Y., Aalto, K., Berntson, L., Dallas, J., Duffy, C., . . . Beukelman, T. (2020). The Initial Treatment of Systemic Juvenile Idiopathic Arthritis: An International Collaboration Among 10 Registries. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 162-165). LA, New Orleans: WILEY. |
| 2020 | Son, M. B., Kimura, Y., Aalto, K., Berntson, L., Dallas, J., Duffy, C., . . . Beukelman, T. (2020). THE INITIAL TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: AN INTERNATIONAL COLLABORATION AMONG 10 REGISTRIES. In ANNALS OF THE RHEUMATIC DISEASES Vol. 79 (pp. 123). ELECTR NETWORK: ELSEVIER. DOI |
| 2019 | Curtis, J., Chen, L., Annapureddy, N., Clinton, C., Clowse, M., Long, M., . . . Beukelman, T. (2019). Comparison of Medication New User Definitions in Multi-Specialty EMR Data. In ARTHRITIS & RHEUMATOLOGY Vol. 71 (pp. 2 pages). GA, Atlanta: WILEY. WoS1 |
| 2019 | Janow, G., Beukelman, T., Kimura, Y., Schneider, R., Mohan, S., Rodich, G., & Son, M. B. (2019). Increasing Use of Biologics over Time in the First Year After Diagnosis of Systemic JIA Among Patients Enrolled in the Childhood Arthritis & Rheumatology Research Alliance (CARRA) Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 71 (pp. 2 pages). GA, Atlanta: WILEY. |
| 2019 | Smitherman, E., Son, M. B., Knight, A., Beukelman, T., Curtis, J., & Hersh, A. (2019). Disease Activity in Childhood-Onset Systemic Lupus Erythematosus: Initial Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 71 (pp. 2 pages). GA, Atlanta: WILEY. |
| 2019 | Rumsey, D., Lougee, A., Matsouaka, R., Collier, D., Schanberg, L., Schenfeld, J., . . . Beukelman, T. (2019). Juvenile Spondyloarthritis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: High Biologic Use, Low Prevalence of HLA-B27, and Equal Sex Representation in Those with Sacroiliitis. In ARTHRITIS & RHEUMATOLOGY Vol. 71 (pp. 3 pages). GA, Atlanta: WILEY. |
| 2019 | Shiff, N., Lougee, A., Matsouaka, R., Collier, D., Kimura, Y., Rumsey, D., . . . Beukelman, T. (2019). Patterns of Etanercept Use in the Childhood Arthritis and Rheumatology Research Alliance Juvenile Idiopathic Arthritis Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 71 (pp. 2 pages). GA, Atlanta: WILEY. |
| 2019 | Mannion, M., Xie, F., & Beukelman, T. (2019). Investigation of Inactive Disease Activity States Among JIA Patients in the CARRA Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 71 (pp. 3 pages). GA, Atlanta: WILEY. |
| 2019 | Brunner, H., Schanberg, L., Kimura, Y., Dennos, A., Eakin, G., Co, D., . . . Beukelman, T. (2019). New Medications Are Needed for Children with Juvenile Idiopathic Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 71 (pp. 3 pages). GA, Atlanta: WILEY. |
| 2019 | Weaver, K., Curtis, J., Beukelman, T., Zhang, X., Kappelman, M., & Long, M. (2019). Use of Infliximab or Adalimumab in Biologic-Naive Patients With Inflammatory Bowel Disease: Study of Patient Reported Outcomes in IBD Partners. In AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 114 (pp. S27-S28). FL, Orlando: LIPPINCOTT WILLIAMS & WILKINS. |
| 2019 | Horton, D. B., Xie, F., Chen, L., Mannion, M. L., Curtis, J. R., Strom, B. L., & Beukelman, T. (2019). Oral glucocorticoids and venous thromboembolism in children. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 28 (pp. 448). WILEY. |
| 2019 | Curtis, J., Chen, L., Oates, J., Clinton, C., Xie, F., Yang, S., & Beukelman, T. (2019). Comparison of new user definitions in multi-specialty EMR data. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 28 (pp. 313-314). WILEY. |
| 2019 | Horton, D., Xie, F., Chen, L., Mannion, M. L., Curtis, J., Strom, B., & Beukelman, T. (2019). ORAL GLUCOCORTICOIDS AND NEWLY TREATED DIABETES MELLITUS, HYPERTENSION, AND THROMBOSIS IN CHILDREN WITH CHRONIC DISEASES. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 960-961). SPAIN, Madrid: BMJ PUBLISHING GROUP. DOI |
| 2019 | Crayne, C., & Beukelman, T. (2019). IVIG-REFRACTORY KAWASAKI DISEASE: DISTILLING THE LITERATURE TO PREDICT OUTCOMES. In JOURNAL OF INVESTIGATIVE MEDICINE Vol. 67 (pp. 581). LA, New Orleans: BMJ PUBLISHING GROUP. DOI |
| 2018 | Horton, D. B., Salas, J., Wec, A., Beukelman, T., Boneparth, A., Guzman, J., . . . Rosenthal, M. (2018). Stopping Medicines for Inactive Juvenile Idiopathic Arthritis: What Do Patients and Families Consider?. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 3 pages). IL, Chicago: WILEY. |
| 2018 | Beukelman, T., Xie, F., & Foeldvari, I. (2018). Assessing the Prevalence of Localized Scleroderma in Childhood Using Dministrative Claims Data from the United States. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 2 pages). IL, Chicago: WILEY. |
| 2018 | Eloseily, E., Crayne, C. B., Mannion, M., Azerf, S., Weiser, P., Beukelman, T., . . . Cron, R. (2018). RITUXIMAB FOR CHRONIC STEROID-DEPENDENT HENOCH-SCHONLEIN PURPURA. In JOURNAL OF INVESTIGATIVE MEDICINE Vol. 66 (pp. 561). LA, New Orleans: BMJ PUBLISHING GROUP. DOI |
| 2017 | Morgan, E. M., Riebschleger, M. P., Horonjeff, J., Consolaro, A., Munro, J. E., Thornhill, S., . . . Bingham, C. O. (2017). Evidence for updating the core domain set of outcome measures for juvenile idiopathic arthritis: Report from a special interest group at OMERACT 2016. In Journal of Rheumatology Vol. 44 (pp. 1884-1888). CANADA, Whistler: J RHEUMATOL PUBL CO. DOI Scopus15 WoS15 Europe PMC13 |
| 2017 | Horton, D. B., Xie, F., Chen, L., Mannion, M. L., Strom, B. L., Curtis, J. R., & Beukelman, T. (2017). Oral Glucocorticoids and Incident Diabetes Mellitus and Hypertension in Children with Chronic Diseases. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 26 (pp. 28-29). WILEY. |
| 2017 | Beukelman, T., Xie, F., Chen, L., Horton, D. B., Lewis, J. D., Mamtani, R., . . . Curtis, J. R. (2017). The Risk of Malignancy Associated with Use of Tumor Necrosis Factor Inhibitors in Childhood. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 26 (pp. 222). WILEY. |
| 2017 | Huang, B., Morgan, E., Chen, C., Liu, J., Adams, M., Beukelman, T., . . . Lovell, D. J. (2017). Comparing Effectiveness of Early Initiation of Biologic Treatment for Newly Diagnosed Juvenile Idiopathic Arthritis Using a Novel Statistics Causal Inference Method Applied to Observational Data. In ARTHRITIS & RHEUMATOLOGY Vol. 69 (pp. 2 pages). CA, San Diego: WILEY. |
| 2017 | Ringold, S., Xie, F., Horton, D. B., Mannion, M. L., Correll, C. K., Dennos, A. C., & Beukelman, T. (2017). Patterns of Medication Use in Non-Systemic Polyarthritis: Data from the Childhood Arthritis and Rheumatology Research Alliance Patient Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 69 (pp. 3 pages). CA, San Diego: WILEY. |
| 2017 | Horton, D. B., Xie, F., Mannion, M. L., Ringold, S., Correll, C. K., Dennos, A. C., & Beukelman, T. (2017). Factors Related to Sustained Discontinuation of Medications for WellControlled JIA in the Childhood Arthritis & Rheumatology Research Alliance Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 69 (pp. 4 pages). CA, San Diego: WILEY. |
| 2017 | Mannion, M. L., Xie, F., Horton, D. B., Ringold, S., Correll, C. K., Dennos, A. C., & Beukelman, T. (2017). Biologic Switching Among JIA Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 69 (pp. 3 pages). CA, San Diego: WILEY. |
| 2017 | Eloseily, E. M. A., Minoia, F., Beukelman, T., Ravelli, A., & Cron, R. Q. (2017). the Ferritin to ESR Ratio: A Simple Measure to Distinguish Macrophage Activation Syndrome from Systemic Arthritis Flare. In ARTHRITIS & RHEUMATOLOGY Vol. 69 (pp. 3 pages). CA, San Diego: WILEY. |
| 2017 | Foeldvari, I., Beukelman, T., & Xie, F. (2017). Assessing the Prevalence of Juvenile Systemic Sclerosis in Childhood Using Administrative Claims Data from the United States. In ARTHRITIS & RHEUMATOLOGY Vol. 69 (pp. 2 pages). CA, San Diego: WILEY. |
| 2017 | Eloseily, E. M. A., Crayne, C., Mannion, M. L., Azerf, S. P., Weiser, P., Beukelman, T., . . . Cron, R. Q. (2017). Rituximab Treatment for Chronic Steroid-Dependent Henoch-Schonlein Purpura. In ARTHRITIS & RHEUMATOLOGY Vol. 69 (pp. 153-155). TX, Houston: WILEY. |
| 2017 | Eloseily, E. M. A., Weiser, P., Haines, H., Mannion, M., Stoll, M. L., Beukelman, T., . . . Cron, R. Q. (2017). Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis. In ARTHRITIS & RHEUMATOLOGY Vol. 69 (pp. 112-113). TX, Houston: WILEY. |
| 2017 | Ringold, S., Xie, F., Kimura, Y., Schanberg, L. E., & Beukelman, T. (2017). Methotrexate use and route of administration in JIA: Results from the Childhood Arthritis & Rheumatology Research Alliance Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 69 (pp. 72-73). TX, Houston: WILEY. |
| 2017 | Horton, D. B., Salas, J., Wec, A., Beukelman, T., Boneparth, A., Haverkamp, K., . . . Rosenthal, M. (2017). How Young People with Juvenile Idiopathic Arthritis and Their Caregivers Weigh the Risks of the Disease and its Treatment: A Mixed-Methods Study. In ARTHRITIS & RHEUMATOLOGY Vol. 69 (pp. 78-81). TX, Houston: WILEY. |
| 2016 | Beukelman, T., Xie, F., Mannion, M. M., Chen, L., Zhang, J., Baddley, J., . . . Curtis, J. R. (2016). The Risk of Hospitalized Infection Associated with New Use of Abatacept versus TNF Inhibitors in Juvenile Idiopathic Arthritis. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 25 (pp. 270-271). WILEY-BLACKWELL. |
| 2016 | Curtis, J., Xie, F., Saag, K., Chen, L., Beukelman, T., Mannion, M., & Yun, H. (2016). Changing Patterns over Time in Opiate Use in US Rheumatoid Arthritis Patients. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 2 pages). DC, Washington: WILEY. |
| 2016 | Beukelman, T., Xie, F., Chen, L., Horton, D., Lewis, J. D., Mamtani, R., . . . Curtis, J. R. (2016). Tumor Necrosis Factor Inhibitors and the Risk of Malignancy in the Treatment of Juvenile Idiopathic Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 2 pages). DC, Washington: WILEY. |
| 2016 | Horton, D. B., Xie, F., Chen, L., Mannion, M., Strom, B. L., Curtis, J., & Beukelman, T. (2016). Oral Glucocorticoids and Rates of Incident Diabetes Mellitus and Hypertension in Children with Juvenile Idiopathic Arthritis and Attention-Deficit/Hyperactivity Disorder. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 4 pages). DC, Washington: WILEY. |
| 2016 | Beukelman, T., Xie, F., Baddley, J., Chen, L., Mannion, M., Saag, K. G., . . . Curtis, J. R. (2016). The Risk of Hospitalized Infection Associated with Initiation of Abatacept Versus TNF Inhibitors in Juvenile Idiopathic Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 3 pages). DC, Washington: WILEY. |
| 2016 | Xie, F., Chen, L., Yun, H., Beukelman, T., & Curtis, J. (2016). Ustekinumab, Apremilast, TNFi and the Risk for Hospitalized Infection in Patients with Psoriasis and Psoriatic Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 2 pages). DC, Washington: WILEY. |
| 2016 | Ringold, S., Kimura, Y., Schanberg, L. E., Natter, M. D., Xie, F., Ilowite, N., . . . Beukelman, T. (2016). Patterns of Medication Use in Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis & Rheumatology Research Alliance Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 3 pages). DC, Washington: WILEY. |
| 2016 | Cron, R. Q., Zhang, M., Bracaglia, C., Prencipe, G., Bemrich-Stolz, C. J., Beukelman, T., . . . Grom, A. A. (2016). A heterozygous <i>RAB27A</i> mutation causes delayed cytolytic granule polarization and hemophagocytic lymphohistiocytosis in 2 unrelated teenagers. In JOURNAL OF IMMUNOLOGY Vol. 196 (pp. 2 pages). WA, Seattle: AMER ASSOC IMMUNOLOGISTS. |
| 2015 | Zhang, J., Curtis, J. R., Xie, F., Mannion, M. L., Lewis, J. D., Clowse, M. E. B., . . . Beukelman, T. (2015). Utilization of Immune-Suppressive Medications during Pregnancy Among Women with Inflammatory Arthritis and Other Autoimmune Diseases. In ARTHRITIS & RHEUMATOLOGY Vol. 67 (pp. 2 pages). CA, San Francisco: WILEY. |
| 2015 | Gmuca, S., Brandon, T., Xiao, R., Pagnini, I., Wright, T. B., Beukelman, T., . . . Weiss, P. F. (2015). Pediatric Enthesitis-Related Arthritis: Variation in Disease Characteristics and Treatments Among 5 Large Centers. In ARTHRITIS & RHEUMATOLOGY Vol. 67 (pp. 2 pages). CA, San Francisco: WILEY. |
| 2015 | Mannion, M. L., Williams, M., Ivankova, N., McGwin, G., Saag, K. G., & Beukelman, T. (2015). Qualitative Assessment of Patient Important Long-Term Outcomes in Juvenile Idiopathic Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 67 (pp. 2 pages). CA, San Francisco: WILEY. |
| 2015 | Mannion, M. L., Pedro, S., Beukelman, T., Curtis, J. R., & Michaud, K. (2015). Comparison of JIA and RA Patients in the National Data Bank for Rheumatic Diseases. In ARTHRITIS & RHEUMATOLOGY Vol. 67 (pp. 2 pages). CA, San Francisco: WILEY. |
| 2015 | Gmuca, S., Brandon, T., Xiao, R., Pagnini, I., Wright, T. B., Beukelman, T., . . . Weiss, P. F. (2015). Phenotypic Differences Between HLA-B27 Positive and Negative Children with Enthesitis-Related Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 67 (pp. 2 pages). CA, San Francisco: WILEY. |
| 2015 | Kimura, Y., Beukelman, T., Morgan-DeWitt, E., Mieszkalski, K. L., Graham, T. B., Ibarra, M. F., . . . Schanberg, L. (2015). Results from the Childhood Arthritis and Rheumatology Research Alliance Systemic JIA Consensus Treatment Plans Pilot Study. In ARTHRITIS & RHEUMATOLOGY Vol. 67 (pp. 2 pages). CA, San Francisco: WILEY. WoS2 |
| 2015 | Beukelman, T., Xie, F., Baddley, J., Chen, L., Mannion, M. L., Saag, K. G., . . . Curtis, J. R. (2015). The Risk of Hospitalized Infection Following Initiation of Biologic Agents Versus Methotrexate in the Treatment of Juvenile Idiopathic Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 67 (pp. 2 pages). CA, San Francisco: WILEY. |
| 2015 | Beukelman, T., Xie, F., Baddley, J., Chen, L., Mannion, M., Saag, K. G., . . . Curtis, J. R. (2015). The Risk of Hospitalized Infection Following Initiation of Biologic Agents versus Methotrexate in the Treatment of Juvennile Idiopathic Arthritis. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 24 (pp. 214). WILEY-BLACKWELL. |
| 2015 | Scott, F. I., Mamtani, R., Brensinger, C. M., Haynes, K., Chiesa-Fuxench, Z. C., Zhang, J., . . . Lewis, J. D. (2015). Risk of Non-melanoma Skin Cancer Recurrence with the Use of Immunosuppressant and Biologic Agents in Autoimmune Disease. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 24 (pp. 47-48). WILEY-BLACKWELL. |
| 2015 | Beukelman, T., Berntson, L., Duffy, C. M., Guzman, J., Kimura, Y., Klotsche, J., . . . Hyrich, K. L. (2015). THE INITIAL TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: AN INTERNATIONAL COLLABORATION AMONG 7 REGISTRIES. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 392-393). BMJ PUBLISHING GROUP. DOI WoS1 |
| 2014 | Kimura, Y., Morgan-DeWitt, E., Mieszkalski, K. L., Graham, T. B., Beukelman, T., Ibarra, M. F., . . . Schanberg, L. (2014). Preliminary Results from the Childhood Arthritis and Rheumatology Research Alliance Systemic JIA Consensus Treatment Plans Pilot Study. In ARTHRITIS & RHEUMATOLOGY Vol. 66 (pp. S1000-S1001). MA, Boston: WILEY. |
| 2014 | Beukelman, T., Carrasco, R., Kimura, Y., Schanberg, L., Thomson, W., & Hyrich, K. L. (2014). The Presentation and Initial Treatment of Systemic Juvenile Idiopathic Arthritis According to Observational Data from the United States and the United Kingdom. In ARTHRITIS & RHEUMATOLOGY Vol. 66 (pp. S1001). MA, Boston: WILEY. |
| 2014 | Tambralli, A., Beukelman, T., Cron, R. Q., & Stoll, M. L. (2014). Safety and Efficacy of Rituximab in Pediatric Lupus and Other Rheumatic Diseases. In ARTHRITIS & RHEUMATOLOGY Vol. 66 (pp. S568). MA, Boston: WILEY. |
| 2014 | Mannion, M. L., Williams, M., McGwin, G., Saag, K. G., & Beukelman, T. (2014). Qualitative Assessment of Important Long-Term Outcomes in Juvenile Idiopathic Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 66 (pp. S129). MA, Boston: WILEY. |
| 2014 | Hinze, C., Foell, D., Johnson, A., Kimura, Y., Spalding, S. J., Morris, P. W., . . . Lovell, D. J. (2014). The Role of Serum S100A12 Protein Levels in Maintaining Inactive Disease on Anti-tumor Necrosis Factor Therapy in Polyarticular Forms of Juvenile Idiopathic Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 66 (pp. S99-S100). FL, Orlando: WILEY. DOI WoS2 |
| 2014 | Mor-Vaknin, N., Rivas, M., Legendre, M., Ye, C. Y., Johnson, A., Huang, B., . . . Markovitz, D. (2014). High Levels of DEK Autoantibodies May Predict Early Flare Following Cessation of Anti-TNF Therapy. In ARTHRITIS & RHEUMATOLOGY Vol. 66 (pp. S65-S66). FL, Orlando: WILEY. DOI |
| 2014 | Lovell, D. J., Johnson, A., Kimura, Y., Spalding, S. J., Morris, P. W., Gottlieb, B. S., . . . Giannini, E. H. (2014). Understanding the Use and Biology of TNF Therapy in JIA-Clinical Outcomes. In ARTHRITIS & RHEUMATOLOGY Vol. 66 (pp. S31-S32). FL, Orlando: WILEY. DOI WoS1 |
| 2014 | Hinze, C., Foell, D., Johnson, A., Kimura, Y., Spalding, S. J., Morris, P. W., . . . Lovell, D. J. (2014). The Role of Serum S100A12 Protein Levels in Disease Flare After Withdrawal of Anti-tumor Necrosis Factor Therapy in Polyarticular Forms of Juvenile Idiopathic Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 66 (pp. S19-S20). FL, Orlando: WILEY. DOI WoS2 |
| 2013 | Mannion, M., Xie, F., Curtis, J. R., & Beukelman, T. (2013). Recent Trends in Medication Usage for the Treatment of Juvenile Idiopathic Arthritis in the US and the Influence of TNF Inhibitors. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 22 (pp. 444-445). WILEY-BLACKWELL. |
| 2013 | Chen, L., Beukelman, T., Bharat, A., Xie, F., Saag, K. G., Delzell, E. S., & Curtis, J. R. (2013). Methods to Link a U.S Arthritis Cohort With Medicare Administrative Claims Data. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 22 (pp. 288-289). WILEY-BLACKWELL. |
| 2013 | Yun, H., Xie, F., Delzell, E. S., Chen, L., Levitan, E., Lewis, J., . . . Curtis, J. R. (2013). Comparative Safety of Biological Agents among Medicare Rheumatoid Arthritis Patients. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 22 (pp. 20-21). WILEY-BLACKWELL. |
| 2013 | Cron, R. Q., Tramballi, A., Beukelman, T., Weiser, P., Atkinson, T. P., & Stoll, M. L. (2013). HIGH DOSES OF INFLIXIMAB IN THE MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 72 (pp. 744). BMJ PUBLISHING GROUP. |
| 2013 | Yun, H., Xie, F., Delzell, E., Chen, L., Levitan, E., Lewis, J., . . . Curtis, J. R. (2013). COMPARATIVE RISKS FOR SERIOUS INFECTIONS ASSOCIATED WITH BIOLOGICS IN HIGH RISK RHEUMATOID ARTHRITIS PATIENTS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 72 (pp. 553-554). BMJ PUBLISHING GROUP. |
| 2013 | Mannion, M., Xie, F., Curtis, J. R., & Beukelman, T. (2013). RECENT TRENDS IN MEDICATION USAGE FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS IN THE UNITED STATES AND THE INFLUENCE OF TNF INHIBITORS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 72 (pp. 149). BMJ PUBLISHING GROUP. |
| 2013 | Yun, H., Xie, F., Delzell, E. S., Chen, L., Levitan, E., Lewis, J., . . . Curtis, J. R. (2013). Comparative Risks Of Herpes Zoster Among RA Patients Switching Biologics In The U. S. Medicare Program.. In ARTHRITIS AND RHEUMATISM Vol. 65 (pp. S1179-S1180). CA, San Diego: WILEY-BLACKWELL. WoS1 |
| 2013 | Yun, H., Xie, F., Delzell, E. S., Chen, L., Levitan, E., Lewis, J., . . . Curtis, J. R. (2013). Risk of Subsequent Infection among Rheumatoid Arthritis Patients Using Biologics.. In ARTHRITIS AND RHEUMATISM Vol. 65 (pp. S1144). CA, San Diego: WILEY-BLACKWELL. |
| 2013 | Yun, H., Xie, F., Delzell, E. S., Chen, L., Levitan, E., Lewis, J., . . . Curtis, J. R. (2013). Comparative Safety Of Biological Agents Among Medicare Rheumatoid Arthritis Patients. In ARTHRITIS AND RHEUMATISM Vol. 65 (pp. S987). CA, San Diego: WILEY-BLACKWELL. WoS1 |
| 2013 | Yun, H., Xie, F., Delzell, E. S., Chen, L., Levitan, E., Lewis, J., . . . Curtis, J. R. (2013). Physician Proclivity To Use Oral Glucocorticoids Among Rheumatoid Arthritis Patients. In ARTHRITIS AND RHEUMATISM Vol. 65 (pp. S449-S450). CA, San Diego: WILEY-BLACKWELL. |
| 2013 | Curtis, J. R., Xie, F., Zhang, J., Chen, L., Yun, H., Schiff, M. H., . . . Ginsberg, S. (2013). Use Of Oral and Subcutaneous MTX In a Commercially Insured Rheumatoid Arthritis Population. In ARTHRITIS AND RHEUMATISM Vol. 65 (pp. S450). CA, San Diego: WILEY-BLACKWELL. |
| 2013 | Mannion, M. L., Xie, F., Curtis, J. R., & Beukelman, T. (2013). Recent Trends In Medication Usage for the Treatment of Juvenile Idiopathic Arthritis and the Influence of TNF Inhibitors.. In ARTHRITIS AND RHEUMATISM Vol. 65 (pp. S336-S337). CA, San Diego: WILEY-BLACKWELL. |
| 2013 | Curtis, J. R., Yun, H., Zhang, J., Xie, F., Chen, L., Levitan, E., . . . Navarro-Millan, I. (2013). Comparing Myocardial Infarction Risks Associated With Biologics Of Varying Mechanisms Of Action Among Older Rheumatoid Arthritis Patients.. In ARTHRITIS AND RHEUMATISM Vol. 65 (pp. S157). CA, San Diego: WILEY-BLACKWELL. WoS1 |
| 2013 | Luca, N., Burnett, H., Ungar, W., Beukelman, T., Feldman, B., Schwartz, G., & Bayoumi, A. (2013). Cost-effectiveness Analysis of Early Biologic Treatment in Polyarticular Juvenile Idiopathic Arthritis. In JOURNAL OF RHEUMATOLOGY Vol. 40 (pp. 988). CANADA, Ottawa: J RHEUMATOL PUBL CO. |
| 2013 | Beukelman, T., Ringold, S., Davis, T. E., DeWitt, E. M., Pelajo, C. F., Weiss, P. F., & Kimura, Y. (2013). DMARD USE IN THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS: A CROSS-SECTIONAL ANALYSIS OF THE CHILDHOOD ARTHRITIS AND RHEUMATOLOGY RESEARCH ALLIANCE (CARRA) REGISTRY. In ANNALS OF THE RHEUMATIC DISEASES Vol. 71 (pp. 438). BMJ PUBLISHING GROUP. DOI |
| 2013 | Beukelman, T., Xie, F., Baddley, J. W., Chen, L., Delzell, E., Grijalva, C., . . . Curtis, J. R. (2013). INCIDENCE OF SELECTED OPPORTUNISTIC INFECTIONS AMONG CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 71 (pp. 270). BMJ PUBLISHING GROUP. DOI |
| 2012 | Verhamme, K. M., de Bie, S., Beukelman, T., Oliveria, S. A., Lasky, T., & Sobel, R. (2012). Small Patients, Big Challenges - Current Topics in Pediatric Pharmacoepidemiology. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 21 (pp. 339-340). WILEY PERIODICALS, INC. |
| 2012 | Curtis, J. R., Chen, L., Beukelman, T., Bharat, A., Xie, F., Saag, K. G., & Delzell, E. (2012). Methods to Link a National Arthritis Cohort with Medicare Administrative Claims Data. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 21 (pp. 46). WILEY PERIODICALS, INC. |
| 2012 | Beukelman, T., Xie, F., Baddley, J. W., Chen, L., Delzell, E., Grijalva, C. G., . . . Curtis, J. R. (2012). Incidence of Selected Opportunistic Infections among Children with Juvenile Idiopathic Arthritis. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 21 (pp. 45). WILEY PERIODICALS, INC. |
| 2012 | Cron, R. Q., Zhang, M., Bemrich-Stolz, C. J., & Beukelman, T. (2012). Rapid and Effective Response to Immunosuppression in Treating Macrophage Activation Syndrome Associated with a Heterozygous Dominant Negative Mutation in RAB27a Leading to Decreased Cytolytic Activity. In ARTHRITIS AND RHEUMATISM Vol. 64 (pp. S1125). DC, Washington: WILEY-BLACKWELL. |
| 2012 | Bingham, C. A., Darbie, L. M., Marsolo, K., Weiss, J. E., Ardoin, S. P., Laxer, R. M., . . . DeWitt, E. M. M. (2012). Improving Delivery of Care for JIA Across a Multi-Center Network Using a Shared Data Registry and Quality Improvement Science: The Pediatric Rheumatology Care and Outcomes Improvement Network. In ARTHRITIS AND RHEUMATISM Vol. 64 (pp. S1101). DC, Washington: WILEY-BLACKWELL. WoS1 |
| 2012 | Luca, N., Burnett, H., Ungar, W., Beukelman, T., Feldman, B. M., Schwartz, G., & Bayoumi, A. (2012). Cost-Effectiveness Analysis of Early Biologic Treatment in Polyarticular Juvenile Idiopathic Arthritis. In ARTHRITIS AND RHEUMATISM Vol. 64 (pp. S501). DC, Washington: WILEY-BLACKWELL. WoS1 |
| 2012 | Weiss, J. E., DeWitt, E. M. M., Beukelman, T., Schanberg, L. E., Schneider, R., & Kimura, Y. (2012). Choice of Systemic JIA Treatment Among Childhood Arthritis and Rheumatology Research Alliance (CARRA) Rheumatologists. In ARTHRITIS AND RHEUMATISM Vol. 64 (pp. S492). DC, Washington: WILEY-BLACKWELL. |
| 2012 | Curtis, J. R., Chen, L., Beukelman, T., Bharat, A., Xie, F., Saag, K. G., & Delzell, E. S. (2012). Methods to Link a US Arthritis Cohort with Medicare Administrative Claims Data. In ARTHRITIS AND RHEUMATISM Vol. 64 (pp. S401). DC, Washington: WILEY-BLACKWELL. WoS2 |
| 2012 | Beukelman, T., Xie, F., Baddley, J., Chen, L., Delzell, E. S., Grijalva, C., . . . Curtis, J. R. (2012). Incidence of Selected Opportunistic Infections Among Children with Juvenile Idiopathic Arthritis.. In ARTHRITIS AND RHEUMATISM Vol. 64 (pp. S329). DC, Washington: WILEY-BLACKWELL. |
| 2011 | DeWitt, E. M., Beukelman, T., Gottlieb, B. S., Griffin, N., Kimura, Y., Barnes, I., & Passo, M. H. (2011). Measuring Quality of Care in Juvenile Idiopathic Arthritis: The Pediatric Rheumatology Care and Outcomes Improvement Network.. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S803-S804). IL, Chicago: WILEY. |
| 2011 | Grijalva, C., Chen, L., Delzell, E. S., Baddley, J., Beukelman, T., Winthrop, K. L., . . . Curtis, J. R. (2011). Initiation of Biologic DMARDs and the Risk of Hospitalization for Infection in Patients with Autoimmune Diseases. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S316). IL, Chicago: WILEY. |
| 2011 | Weiss, P., Beukelman, T., Schanberg, L. E., Kimura, Y., & Colbert, R. A. (2011). Enthesitis Is a Significant Predictor of Decreased Quality of Life, Function, and Arthritis-Specific Pain Across Juvenile Idiopathic Arthritis (JIA) Categories: Preliminary Analyses From the CARRAnet Registry.. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S105). IL, Chicago: WILEY. WoS7 |
| 2011 | DeWitt, E. M., Beukelman, T., Nigrovic, P. A., Onel, K., Prahalad, S., Schneider, R., . . . Kimura, Y. (2011). Development of Consensus Treatment Plans for New-Onset Systemic Juvenile Idiopathic Arthritis.. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S106). IL, Chicago: WILEY. |
| 2011 | Beukelman, T., Ringold, S., Davis, T., DeWitt, E. M. M., Pelajo, C. F., Weiss, P., & Kimura, Y. (2011). Utilization of Biologic and Non-Biologic Disease Modifying Anti-Rheumatic Drugs in the Treatment of Juvenile Idiopathic Arthritis: A Cross-Sectional Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry.. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S104). IL, Chicago: WILEY. |
| 2011 | Miller, M. L., Beukelman, T., Lales, G., McKenna, S., Ruprecht, J., Curran, M. L., & Klein-Gitelman, M. S. (2011). Application and Examination of the Key Clinical Parameters From the 2011 ACR Recommendations for the Treatment of JIA Using Electronic Medical Record-Derived Data From a Clinical Cohort. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S98-S99). IL, Chicago: WILEY. |
| 2011 | Grijalva, C. G., Chen, L., Delzell, E., Baddley, J. W., Beukelman, T., Griffin, M. R., . . . Curtis, J. R. (2011). Initiation of Biologic DMARDs and the Risk of Hospitalized Bacterial Infections in Patients with Rheumatoid Arthritis. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 20 (pp. S182-S183). WILEY-BLACKWELL. |
| 2011 | Beukelman, T., Xie, F., Chen, L., Baddley, J. W., Delzell, E., Grijalva, C. G., . . . Curtis, J. R. (2011). Rates of Hospitalized Bacterial Infection Associated with Juvenile Idiopathic Arthritis and Its Treatment. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 20 (pp. S13-S14). WILEY-BLACKWELL. |
| 2011 | Cron, R. Q., Beukelman, T., Bemrich-Stolz, C., & Watts, R. G. (2011). IL-1 ANTAGONISM FOR TREATMENT OF MACROPHAGE ACTIVATION SYNDROME. In PEDIATRIC BLOOD & CANCER Vol. 56 (pp. 701). WILEY PERIODICALS, INC. |
| 2010 | Cron, R., Genin, A., Brunner, M., Scalzi, L., Mishra, N., Beukelman, T., & Mehta, J. (2010). Prolonged CD154 expression in pediatric lupus CD4 T cells correlates with increased CD154 transcription, increased NFAT activity, and glomerulonephritis. In JOURNAL OF IMMUNOLOGY Vol. 184 (pp. 1 page). AMER ASSOC IMMUNOLOGISTS. |
| 2008 | Beukelman, T., Saag, K. G., Curtis, J. R., Nair, R., Kilgore, M. L., & Pisu, M. (2008). The cost-effectiveness of a multi-modal intervention for the prevention of glucocorticoid-induced osteoporosis. In ARTHRITIS AND RHEUMATISM Vol. 58 (pp. S739-S740). CA, San Francisco: WILEY-LISS. |
| 2008 | Cron, R. Q., Beukelman, T., Reed, A. B., & Behrens, E. M. (2008). IL-1 antagonism for treatment of macrophage activation syndrome. In ARTHRITIS AND RHEUMATISM Vol. 58 (pp. S247-S248). CA, San Francisco: WILEY-LISS. |
| 2006 | Beukelman, T., Guevara, J., Albert, D. A., Sherry, D. D., & Burnham, J. (2006). Characterization of the treatment of juvenile idiopathic oligoarthritis by pediatric rheumatologists in the United States and Canada.. In ARTHRITIS AND RHEUMATISM Vol. 54 (pp. 4030). DC, Washington: WILEY-LISS. |
| 2006 | Behrens, E. M., Beukelman, T., Paessler, M., & Cron, R. Q. (2006). Occult macrophage activation syndrome in systemic juvenile idiopathic arthritis.. In ARTHRITIS AND RHEUMATISM Vol. 54 (pp. S695). DC, Washington: WILEY-LISS. |
| 2005 | Beukelman, T., Arabshahi, B., Cahill, A. M., Kaye, R. D., & Cron, R. Q. (2005). Benefit of intra-articular corticosteroid injection under fluoroscopic guidance for subtalar arthritis in juvenile idiopathic arthritis.. In ARTHRITIS AND RHEUMATISM Vol. 52 (pp. S85). CA, San Diego: WILEY-BLACKWELL. |
| Year | Citation |
|---|---|
| 2026 | Ho, J. N., Hillen, J., Nassar, N., Zoega, H., Beukelman, T., Pratt, N., & Daniels, B. (2026). Uptake and Use of Biologic Therapies in Paediatric Immune-Mediated Inflammatory Diseases: An Australian Population-Based Study. Poster session presented at the meeting of Pharmacoepidemiology and Drug Safety. WILEY. DOI |
| Year | Citation |
|---|---|
| 2019 | Saper, V. E., Chen, G., Deutsch, G. H., Guillerman, R. P., Birgmeier, J., Jagadeesh, K., . . . Mellins, E. D. (2019). An emergent, high-fatality lung disease in systemic juvenile arthritis. DOI |
| Date | Role | Editorial Board Name | Institution | Country |
|---|---|---|---|---|
| 2019 - 2021 | Board Member | Arthritis Care and Research | Arthritis Care and Research | United States |
| 2012 - 2025 | Board Member | Journal of Rheumatology | Journal of Rheumatology | Canada |
Connect With Me
External Profiles
